Evidence of centromeric histone 3 chaperone involved in DNA damage repair pathway in budding yeast Authors: Prakhar Agarwal, Anushka Alekar, Shubhomita Mallick, Kannan Harini, Santanu K Ghosh, Yamini Dalal Published: 2025 ABSTRACT The centromeric protein-A (CENP-A) is an evolutionarily conserved histone H3 variant that marks the identity of the centromeres. Several mechanisms regulate the centromeric deposition of CENP-A as its mislocalization causes erroneous chromosome segregation, leading to aneuploidy-based diseases, including cancers. The most crucial deposition factor is a CENP-A specific chaperone, HJURP (Scm3 in budding yeast), which specifically binds to CENP-A. However, the discovery of HJURP as a DDR (DNA damage repair) protein and evidence of its binding to Holliday junctions in vitro indicate a CENP-A-deposition-independent role of these chaperones. In this study, using budding yeast, we demonstrate that Scm3 is crucial for the DDR pathway as Scm3-depleted cells are sensitive to DNA damage. We further observe that Scm3 depletion genetically interacts with the rad52 DDR mutant and is compromised in activating DDR-mediated arrest. We demonstrate that Scm3 associates with DNA damage sites and undergoes posttranslational modifications upon DNA damage. Overall, from this report and earlier studies on HJURP, we conclude that DDR functions of CENP-A chaperones are conserved across eukaryotes. The revelation that these chaperones promote genome stability in more than one pathway has clinical significance. Introduction The faithful replication and partitioning of the replicated chromatin as chromosomal units from mother to daughter cell is important for cell survival. New nucleosomes are assembled on DNA during replication, which requires the deposition of histones in a highly regulated step-by-step process that involves the deposition of an (H3-H4)2 tetramer followed by two H2A-H2B dimers (Hammond et al., 2017; Ransom et al., 2010). The deposition of histones is assisted by a group of proteins called histone chaperones. These chaperones physically interact with the histones in a pre-nucleosomal complex and thus prevent premature histone-DNA interaction or nucleosome assembly (Burgess and Zhang, 2013; Ransom et al., 2010). The deposition of the canonical histones occurs mainly during DNA replication via a replication-coupled (RC) pathway using chaperones dedicated to the RC pathway (Serra-Cardona and Zhang, 2018). For instance, Asf1 and CAF-1 deposit (H3-H4)2 tetramers (Burgess and Zhang, 2013; De Koning et al., 2007) and Nap1 facilitates (H2A-H2B)2 deposition (De Koning et al., 2007; Eitoku et al., 2008) into nucleosomes. On the other hand, variant histones that earmark specialized chromatin domains are deposited at specific sites throughout the cell cycle using the replication-independent (RI) pathway using variant-specific chaperones dedicated to the RI pathway (Smith, 2002). For instance, deposition of the variant histones H2A.Z, CENP-A, and MacroH2A, important in transcriptional activation (Gerton et al., 2000), kinetochore formation (Earnshaw and Rothfield, 1985; Earnshaw and Tomkiel, 1992; McKinley and Cheeseman, 2016) and X chromosome inactivation (Sun and Bernstein, 2019), occurs via chromatin remodelers (Fan et al., 2022), the HJURP chaperone (Dunleavy et al., 2009; Foltz et al., 2009), and acidic nuclear phosphoprotein 32B (ANP32B; Mandemaker et al., 2023), respectively. Almost all eukaryotes harbor CENP-A at centromeres, which promotes the formation of kinetochores at those loci (Blower and Karpen, 2001; Buchwitz et al., 1999; Howman et al., 2000; Stoler et al., 1995; Van Hooser et al., 2001; Earnshaw and Rothfield, 1985). In metazoans, HJURP (Holliday junction recognition protein) is the cognate chaperone (Dunleavy et al., 2009; Foltz et al., 2006) of CENP-A. The CENP-A binding domain at the N-terminus of HJURP is highly conserved (Aravind et al., 2007; Sanchez-Pulido et al., 2009; Shuaib et al., 2010). Despite the well-established function of HJURP in CENP-A deposition at centromeres, HJURP was initially identified as a protein involved in the DNA damage response (DDR; Kato et al., 2007). HJURP was so named because of its ability to bind in vitro to Holliday junction DNA substrates generated in vivo during DNA damage repair through homologous recombination (Kato et al., 2007). HJURP was found to interact physically with the DNA damage sensing complex MRN (Mre11-Rad50-Nbs1), and the interaction was found to increase significantly upon induction of double-strand breaks (DSBs) (Kato et al., 2007). As a corollary, the level and subcellular localization of HJURP change in cells treated with DNA-damaging agents such as ionizing radiation (IR), hydroxyurea (HU), cisplatin, and camptothecin (CPT; Kato et al., 2007). Finally, the expression of HJURP was found to be regulated by ATM, a DDR kinase, as no protein expression was observed in ATM-deficient cancerous cell lines. Notably, HJURP has been found to be diffusely present throughout the nucleus (Dunleavy et al., 2009; Kato et al., 2007), in agreement with its involvement in DDR. Given the functions of HJURP in CENP-A deposition and DDR pathway, it is not surprising that misregulation of HJURP is involved in disease states. HJURP is considered an oncogene as its overexpression has been associated with cancers (Chen et al., 2018; Kang et al., 2020) including breast cancer (Coates et al., 2010; Hu et al., 2010; Montes de Oca et al., 2015), lung cancer (Kato et al., 2007), ovarian cancer (Dou et al., 2022), glioblastoma (Valente et al., 2013; Valente et al., 2009), hepatocellular carcinoma (Chen et al., 2018; Hu et al., 2017; Luo et al., 2022), colorectal cancer (Kang et al., 2020), and pancreatic cancer (Wang et al., 2020). Consequently, the inhibition of HJURP attenuates the cancer cells' properties and increases the survival rate of patients, and thus, HJURP acts as a prognostic marker for several cancers (Kang et al., 2020; Lai et al., 2021). In budding yeast, Cse4 and Scm3 are the homologs of CENP-A and HJURP, respectively. Scm3 deposits Cse4 at centromeres during S phase through its physical interaction with Ndc10, which binds to centromeric DNA as part of the CBF3 complex (Camahort et al., 2007; Cho and Harrison, 2012; Cho and Harrison, 2011). Notably, following the deposition of Cse4, Scm3 remains associated with the centromeres throughout the cell cycle (Wisniewski et al., 2014; Xiao et al., 2011), and like HJURP, Scm3 has been found on non-centromeric chromatin (Mizuguchi et al., 2007). Besides the highly conserved CENP-A binding domain, both HJURP and Scm3 also harbor a homologous DNA binding domain (Figure 1—figure supplement 1A), which is predicted to be evolutionarily conserved in all vertebrates and fission yeast (Müller et al., 2014). Overexpression of Scm3, like HJURP, causes chromosome instability, and it is believed that Scm3, when in excess, binds to centromeric DNA independently and leads to chromosome missegregation (Choy et al., 2012; Mishra et al., 2011). Both Scm3 and HJURP form homo-dimers, and in an in vitro assay, Scm3 and HJURP bind to non-centromeric DNA (Kato et al., 2007; Stoler et al., 2007; Xiao et al., 2011). Non-homologous proteins, such as budding yeast Ndc10 and mammalian Mis18, are critical for Cse4 and CENP-A deposition, respectively, but they bind to Scm3 and HJURP through regions other than the conserved Cse4/CENP-A- and DNA-binding domain of these chaperones. Therefore, despite the significant difference in polypeptide length between HJURP and Scm3 (748 vs 229), their functions appear conserved from humans to yeast. Given the physical interaction of HJURP with the MRN complex, it is highly plausible that Scm3 might also interact with DDR proteins in yeast. Altogether, from the above observations, we hypothesize that Scm3, like HJURP, may be involved in the DDR pathway in budding yeast. In this work, we report that cells lacking Scm3 are sensitive to DNA-damaging agents and are compromised in DNA damage repair. In addition to the known functions of HJURP in the DDR pathway, in this report, we show that Scm3 is required for mounting DDR-dependent checkpoint activation. Importantly, we demonstrate that Scm3 associates with DNA damage sites upon induction of DNA damage and persists there, perhaps to facilitate damage repair. Our results suggest that the phosphorylation of Scm3 might be involved in its DDR-related functions. Taken together, this study reveals an evolutionary kinship amongst CENP-A chaperones in conferring genome stability through efficient DNA damage repair, besides their canonical role in CENP-A deposition. Results Scm3-depleted cells are sensitive to MMS-mediated DNA damage Yeast cells compromised in DNA damage repair (DDR) show sensitivity to DNA-damaging agents such as methyl methane sulfonate (MMS), HU, and CPT. To investigate the role of Scm3 in DDR, we tagged Scm3 with an auxin-inducible degron to conditionally suppress Scm3 function (SCM3-AID; Nishimura et al., 2009) since the protein is essential for growth (Camahort et al., 2007; Mizuguchi et al., 2007; Stoler et al., 2007), and assayed the behavior of Scm3-depleted cells in the presence of DNA damaging agents. Since cells devoid of the homologous recombination protein, Rad52, are known to show extreme sensitivity to such drugs, rad52∆ cells were used as a positive control in our assays (Plate et al., 2008; Kaytor and Livingston, 1994). Mid-log grown cells were harvested, serially diluted, and spotted on plates supplemented with auxin and DNA damaging agents (MMS, HU, CPT) in different combinations (Figure 1A, Figure 1—figure supplement 2A). We observed that SCM3-AID cells (three independent transformants) were sensitive to MMS in the presence but not the absence of auxin. rad52∆ cells, as expected, were sensitive to MMS but not to auxin (Figure 1A). To quantify the levels of sensitivity towards MMS, we performed a colony-forming unit (CFU) count assay where SCM3-AID cells were pre-grown in rich media without auxin to mid-log phase before an equal number of cells was plated on media supplemented with auxin and MMS in different combinations (Figure 1B). The number of colonies formed after 36 hr was counted, and the number of colonies on plates free of auxin and MMS was interpreted as 100% cell viability. We observed a statistically significant drop in cell viability on the plate supplemented with both auxin and MMS compared to auxin alone (Figure 1B). Depletion of Scm3 causes sensitivity to MMS. (A) Wild-type (SCM3), SCM3-AID (three independent transformants), and rad52∆ cells, grown till mid-log, were serially diluted and spotted on the indicated plates. The plates were incubated at 30 °C for 24–48 hr before imaging. (B) An equal number of mid-log grown SCM3-AID cells were spread on plates containing the indicated supplements. Cell viability was estimated from the number of colonies that appeared after incubation at 30 °C for 2 days (see Materials and methods). The colony number on the plate without auxin and MMS was taken as 100% viability. Error bars represent the standard error of the mean. The p-values were estimated by a one-way ANOVA test followed by Tukey’s multiple comparison test from three independent experiments. (C) Wild-type (SCM3), SCM3-AID, SCM3-AID rad52∆, and rad52∆ cells, grown till mid-log, were serially diluted and spotted in the presence of the indicated auxin concentrations. The plates were incubated at 30 °C for 24–48 hr before imaging. (D) The cells of the strains used in (C) were grown till mid-log and treated with 0.75 mM auxin for the indicated duration before they were washed, serially diluted, and spotted on YPD plates that were incubated at 30 °C for 24–48 hr before imaging. Figure 1—source data 1.Source data for Figure 1B. Source data for Figure 1B. Figure 1—figure supplement 1.NLS domain and the C-terminal amino acids of Scm3 are dispensable for the DDR function.(A) The domain organization of HJURP and Scm3. HCTD, HJURP C-terminal domain; NES, nuclear export signal; BR/NLS, bromodomain, or nuclear localization signal; D/E, D/E rich region. (B) The domain organization of the Scm3 mutants used for the DNA damage sensitivity assay. Yeast cells harboring indicated Scm3 versions as the sole source of Scm3 were grown till mid-log and were serially diluted and spotted on the indicated plates. The plates were incubated at 30 °C for 24–48 hr before imaging. NLS domain and the C-terminal amino acids of Scm3 are dispensable for the DDR function. (A) The domain organization of HJURP and Scm3. HCTD, HJURP C-terminal domain; NES, nuclear export signal; BR/NLS, bromodomain, or nuclear localization signal; D/E, D/E rich region. (B) The domain organization of the Scm3 mutants used for the DNA damage sensitivity assay. Yeast cells harboring indicated Scm3 versions as the sole source of Scm3 were grown till mid-log and were serially diluted and spotted on the indicated plates. The plates were incubated at 30 °C for 24–48 hr before imaging. Figure 1—figure supplement 2.Cells lacking Scm3 are sensitive to various DNA damaging agents.(A)SCM3, SCM3-AID, and rad52∆ cells grown till mid-log were serially diluted and spotted on the indicated plates. The plates were incubated at 30 °C for 24–48 hr before imaging. (B) SCM3 and SCM3-AID cells were grown till mid-log and were treated with auxin for 2 hr. The cells were harvested and analyzed for DAPI staining and bud morphology to visualize the cell cycle stages. At least 100 cells were analyzed from two independent experiments. (C) Western blot analysis for the detection of Scm3 in a no-tag strain (NT) or in strains harboring SCM3-6HA or SCM3-6HA-AID in the absence or presence of auxin. (D) SCM3, SCM3-AID (three independent transformants), and rad52∆ cells, grown till mid-log, were pretreated with 0.75 mM auxin for 2 hr before they were washed, serially diluted, and spotted on the indicated plates. (E) The graph shows the cell viability percentage of the indicated strains treated with 0.01% MMS. An equal number of cells pretreated with 0.75 mM auxin were spread on YPD plates supplemented without or with 0.01% MMS. Cell viability was estimated from the number of colonies that appeared after incubation at 30 °C for 2 days (see Materials and methods). The colony number on the plate without MMS was taken as 100% viability. Error bars represent the standard error of the mean. The p-values were determined by a one-way ANOVA test followed by Tukey’s multiple comparison test from three independent experiments. (F) The cells from the indicated strains were grown till mid-log, serially diluted, and spotted on the indicated plates. The plates were incubated at 30 °C for 24–48 hr before imaging. Figure 1—figure supplement 2—source data 1.Original files for western blot analysis displayed in Figure 1—figure supplement 2C. Figure 1—figure supplement 2—source data 2.Original files for western blot analysis displayed in Figure 1—figure supplement 2C indicating relevant bands. Figure 1—figure supplement 2—source data 3.Source data for Figure 1—figure supplement 2E. Cells lacking Scm3 are sensitive to various DNA damaging agents. (A)SCM3, SCM3-AID, and rad52∆ cells grown till mid-log were serially diluted and spotted on the indicated plates. The plates were incubated at 30 °C for 24–48 hr before imaging. (B) SCM3 and SCM3-AID cells were grown till mid-log and were treated with auxin for 2 hr. The cells were harvested and analyzed for DAPI staining and bud morphology to visualize the cell cycle stages. At least 100 cells were analyzed from two independent experiments. (C) Western blot analysis for the detection of Scm3 in a no-tag strain (NT) or in strains harboring SCM3-6HA or SCM3-6HA-AID in the absence or presence of auxin. (D) SCM3, SCM3-AID (three independent transformants), and rad52∆ cells, grown till mid-log, were pretreated with 0.75 mM auxin for 2 hr before they were washed, serially diluted, and spotted on the indicated plates. (E) The graph shows the cell viability percentage of the indicated strains treated with 0.01% MMS. An equal number of cells pretreated with 0.75 mM auxin were spread on YPD plates supplemented without or with 0.01% MMS. Cell viability was estimated from the number of colonies that appeared after incubation at 30 °C for 2 days (see Materials and methods). The colony number on the plate without MMS was taken as 100% viability. Error bars represent the standard error of the mean. The p-values were determined by a one-way ANOVA test followed by Tukey’s multiple comparison test from three independent experiments. (F) The cells from the indicated strains were grown till mid-log, serially diluted, and spotted on the indicated plates. The plates were incubated at 30 °C for 24–48 hr before imaging. Figure 1—figure supplement 2—source data 1.Original files for western blot analysis displayed in Figure 1—figure supplement 2C. Original files for western blot analysis displayed in Figure 1—figure supplement 2C. Figure 1—figure supplement 2—source data 2.Original files for western blot analysis displayed in Figure 1—figure supplement 2C indicating relevant bands. Original files for western blot analysis displayed in Figure 1—figure supplement 2C indicating relevant bands. Figure 1—figure supplement 2—source data 3.Source data for Figure 1—figure supplement 2E. Source data for Figure 1—figure supplement 2E. Figure 1—figure supplement 3.MMS sensitivity of the cells lacking Scm3 is independent of its kinetochore function or effect on cell cycle progression.(A) Wild-type, NDC10-AID, MIF2-AID, and rad52∆ cells grown till mid-log were serially diluted and spotted on the indicated plates. The plates were incubated at 30 °C for 24–48 hr before imaging. (B) Wild-type, ctf19∆, and rad52∆ cells grown till mid-log were serially diluted and spotted on the indicated plates. The plates were incubated at 30 °C for 24–48 hr before imaging. MMS sensitivity of the cells lacking Scm3 is independent of its kinetochore function or effect on cell cycle progression. (A) Wild-type, NDC10-AID, MIF2-AID, and rad52∆ cells grown till mid-log were serially diluted and spotted on the indicated plates. The plates were incubated at 30 °C for 24–48 hr before imaging. (B) Wild-type, ctf19∆, and rad52∆ cells grown till mid-log were serially diluted and spotted on the indicated plates. The plates were incubated at 30 °C for 24–48 hr before imaging. Since the presence of auxin alone suppresses the growth of SCM3-AID cells, we took yet another approach to examine the sensitivity of these cells to MMS. We pre-treated the cells with 0.75 mM auxin for 2 hr to deplete Scm3, then washed out auxin and spotted on plates containing different concentrations of MMS, without auxin. The depletion of Scm3 was verified by observing a higher percentage of G2/M arrested cells and by Western blot verifying the degradation of Scm3-AID after auxin treatment (Figure 1—figure supplement 2B–C). Here also, we found that Scm3-depleted cells were more sensitive to MMS as compared to the wild-type cells (Figure 1—figure supplement 2D). To quantify the sensitivity observed by this approach, we performed a CFU count, as mentioned above. Following auxin pretreatment, an equal number of wild-type, SCM3-AID, and rad52∆ cells were spread on plates with or without 0.01% MMS. We again found a statistically significant drop in cell viability on the MMS plate when Scm3 was pre-depleted (Figure 1—figure supplement 2E). The rad52∆ cells, as the positive control, showed high sensitivity to MMS, as expected. The increased sensitivity of Scm3-depleted cells to DNA-damaging agents could be due to the weakening of the kinetochores, as Scm3-mediated deposition of Cse4 promotes kinetochore assembly, or due to the delay in the cell cycle, as Scm3-depleted cells arrest in late G2/M phase (Camahort et al., 2007; Cho and Harrison, 2011). If either of these hold true, perturbation of the kinetochore by degradation of other kinetochore proteins or wild-type cells arrested at metaphase would likely show a similar sensitivity to MMS. In budding yeast, Ndc10 is recruited to the centromeres upstream of Scm3 (Lang et al., 2018), whereas the centromeric localization of Mif2, another essential inner kinetochore protein, depends on Scm3 and Cse4 (Xiao et al., 2017). We constructed NDC10-AID and MIF2-AID strains and used them for our assay to represent proteins independent or dependent on Scm3 for centromeric localization, respectively. We also included one non-essential kinetochore protein, Ctf19, a protein of the COMA complex, to remove any possible misjudgment in distinguishing a cell-growth-arrest phenotype occurring due to drug sensitivity vs. auxin-mediated degradation of essential proteins. The COMA complex is directly recruited to the centromeres through interaction with the N-terminal tail of Cse4, hence dependent on Scm3 (Chen et al., 2000; Fischböck-Halwachs et al., 2019). Mid-log phase cells were harvested and spotted on plates with or without MMS and/or auxin; however, we did not observe any increased sensitivity of such cells to MMS (Figure 1—figure supplement 3). Further, wild-type cells, when challenged in the presence of nocodazole and MMS, also did not show an increased sensitivity to MMS. Therefore, the increased sensitivity to MMS in Scm3-depleted cells but not in other kinetochore mutant or metaphase-arrested cells indicates that Scm3 possesses an additional function in genome stability besides its role in kinetochore assembly. Since HJURP is involved in DDR through the HR pathway (Kato et al., 2007), Scm3-depleted cells are expected to interact genetically with HR mutants if Scm3 shares this function with HJURP. We therefore tested genetic interaction between Scm3-depleted and rad52∆ cells, as Rad52 is essential for efficient homologous recombination in S. cerevisiae (Barlow and Rothstein, 2010; Lee et al., 2003). In the presence of auxin, the double mutant grew slowly compared to the single mutants and the wild-type strain (Figure 1C). To further validate the genetic interaction between the two genes, mid-log grown cells were pre-treated with 0.75 mM auxin to deplete Scm3 before cells were spotted on YPD plates. Again, we observed that the double mutant grew slower than the wild type and single mutants (Figure 1D). Next, we wanted to investigate how the double mutant behaves when challenged by a DNA damaging agent. As expected, when the double mutant was spotted in the presence of 0.005% MMS, the single mutants grew better than the double mutant (Figure 1—figure supplement 2F). These results indicate a genetic interaction between Scm3 depletion and rad52 deletion. Further, we wanted to identify the regions in Scm3 whose loss confers sensitivity to DNA damage. Scm3 contains two essential conserved regions, NES (nuclear export signal) and HR (heptad repeat), having functions in DNA and Cse4 binding, respectively (Figure 1—figure supplement 1A). Scm3 also has a non-essential D/E-rich region, which is important for protein stability but not involved in Cse4 binding (Stoler et al., 2007). In addition, Scm3 possesses two BR (bromodomain) regions, each harboring a candidate NLS (nuclear localization signal). Deletion of the C-terminal 25 amino acids or the bromodomain regions does not cause cell lethality (Shivaraju et al., 2011; Stoler et al., 2007). We used these non-essential scm3 mutants (Shivaraju et al., 2011) as the sole source of Scm3 and challenged the cells to MMS and CPT along with wild-type Scm3-expressing cells as a control. We found no growth defect in response to MMS or CPT (Figure 1—figure supplement 1B), suggesting that at least the C-terminal 25 amino acids and bromodomain regions are not important for the DDR function of Scm3. This indicates that the essential NES and/or HR might be involved, but this is technically difficult to test using growth-based assays. From these results, we conclude that the loss of Scm3 confers sensitivity to DNA-damaging agents, indicating that Scm3, like its mammalian homolog HJURP, may play a role in the DDR pathway. The loss of Scm3 generates more Rad52 foci Having shown that the Scm3-depleted cells are sensitive to DNA damage, we hypothesized that these cells might be deficient in repairing DNA damage. To examine this, we wished to visualize Rad52-GFP foci in these cells. In budding yeast, the primary pathway to repair double-strand breaks is through homologous recombination (HR) mediated by Rad52. Therefore, loss of RAD52 causes these DNA breaks to accumulate upon damage (Dornfeld and Livingston, 1991; Lisby et al., 2003; Lisby et al., 2001). Mid-log phase RAD52-GFP SCM3-AID cells were treated with auxin or left untreated for 2 hr. The cultures were then split and incubated with or without 0.02% MMS for 90 min (Figure 2A), followed by visualization of Rad52-GFP foci (Figure 2B). Interestingly, we observed that 13% of Scm3-depleted (+auxin) cells showed Rad52-GFP foci in the absence of MMS, in contrast to only 5% of wild-type cells (Figure 2C, untreated). Consistent with this observation, when these cells were challenged with MMS, the number of Rad52-GFP foci increased, and Scm3-depleted cells still showed Rad52-GFP foci more frequently (70%) than wild-type cells (45%) (Figure 2C, 0.02% MMS). Moreover, while the Scm3-depleted cells harbored an average of ~3 foci in MMS, the wild type showed ~2 foci per cell (Figure 2D). To rule out the possibility that auxin treatment alone can cause increased Rad52-GFP foci formation, we challenged the wild-type (RAD52-GFP) cells with auxin or DMSO and counted the number of cells with Rad52-GFP foci. We did not observe an increase in Rad52-GFP-positive cells when treated with auxin +DMSO, as compared to only DMSO (Figure 2—figure supplement 1A–B). We further quantified the distribution of cells with 1, 2, 3, or >4 Rad52-GFP foci in SCM3-AID cells treated with MMS with or without auxin. Scm3-depleted cells showed a significantly higher number of cells with 3 or >4 Rad52-GFP foci (Figure 2—figure supplement 1C). These results demonstrate that loss of Scm3 results in either an increased number of DSBs or a change in repair kinetics. Depletion of Scm3 causes more Rad52 foci in the presence or absence of MMS. (A) Schematic of the experimental strategy for visualization of Rad52-GFP foci in the RAD52-GFP SCM3-AID cells either in the presence of DMSO or auxin (Scm3 depleted) and each either treated with MMS or left untreated. (B) Representative images showing different patterns of Rad52-GFP foci. Rad52-GFP produces a nuclear signal (row 1) in the absence of DNA damage, but with damage coalesces to form bright foci (rows 2–5) representing the DNA repair sites. (C) The percentage of indicated cells containing Rad52-GFP foci with or without MMS treatment for 90 min. (D) The average number of Rad52-GFP foci per MMS-treated cell from the experiment described in (C). At least 300 cells were analyzed from three independent experiments for each set in (C) and (D). Error bars represent the standard error of the mean. The p-values were estimated by an unpaired two-tailed Student’s t-test. Scale bar = 2 µm. Figure 2—source data 1.Source data for Figure 2. Source data for Figure 2. Figure 2—figure supplement 1.Depletion of Scm3 leads to the formation of multiple DSB (Rad52-GFP) foci.(A) Schematic of the experimental strategy that was followed for visualization of Rad52-GFP foci in the wild-type cells treated with DMSO or auxin (Scm3 depleted) for 2 hr. (B) The percentage of Rad52-GFP foci positive cells harvested from (A). (C) The percentage of wild type (SCM3-AID) and Scm3-depleted (SCM3-AID+Auxin) cells harboring indicated numbers of Rad52-GFP foci upon treatment with 0.02% MMS. At least 300 cells were analyzed from three independent experiments for each set in (C) and (D). Error bars represent the standard error of the mean. The p-values were determined by an unpaired two-tailed Student’s t-test. Figure 2—figure supplement 1—source data 1.Source data for Figure 2—figure supplement 1. Depletion of Scm3 leads to the formation of multiple DSB (Rad52-GFP) foci. (A) Schematic of the experimental strategy that was followed for visualization of Rad52-GFP foci in the wild-type cells treated with DMSO or auxin (Scm3 depleted) for 2 hr. (B) The percentage of Rad52-GFP foci positive cells harvested from (A). (C) The percentage of wild type (SCM3-AID) and Scm3-depleted (SCM3-AID+Auxin) cells harboring indicated numbers of Rad52-GFP foci upon treatment with 0.02% MMS. At least 300 cells were analyzed from three independent experiments for each set in (C) and (D). Error bars represent the standard error of the mean. The p-values were determined by an unpaired two-tailed Student’s t-test. Figure 2—figure supplement 1—source data 1.Source data for Figure 2—figure supplement 1. Source data for Figure 2—figure supplement 1. Figure 2—figure supplement 2.Depletion of Scm3 causes increased Rad52 foci along the cell cycle and cell death.(A) The schematic of the experimental strategy that was followed for visualization of Rad52-GFP foci in the bar1∆ RAD52-GFP SCM3-AID cells at different stages of the cell cycle in the presence of DMSO (wild-type) or auxin (Scm3 depleted) and each either treated with 0.02% MMS or left untreated. All the cells were arrested eventually at metaphase using nocodazole. (B) Representative images showing different patterns of Rad52 foci at indicated time points following their release from alpha factor. (C, D) The percentage of Rad52-GFP foci in the indicated cells harvested as shown in (A). (E) Cells harvested, as shown in Figure 2A, were analyzed for cell viability using PI staining. Representative images show PI-positive cells (dead cell, arrow) and PI-negative cells (live cell, arrowhead). The percentage of dead cells with or without MMS treatment for 90 min is graphically shown. At least 250 cells were analyzed for each set in (C, D), and (E) from three independent experiments. Error bars represent the standard error of the mean. The p-values were determined by an unpaired two-tailed Student’s t-test. Scale bar = 2 µm. Figure 2—figure supplement 2—source data 1.Source data for Figure 2—figure supplement 2. Depletion of Scm3 causes increased Rad52 foci along the cell cycle and cell death. (A) The schematic of the experimental strategy that was followed for visualization of Rad52-GFP foci in the bar1∆ RAD52-GFP SCM3-AID cells at different stages of the cell cycle in the presence of DMSO (wild-type) or auxin (Scm3 depleted) and each either treated with 0.02% MMS or left untreated. All the cells were arrested eventually at metaphase using nocodazole. (B) Representative images showing different patterns of Rad52 foci at indicated time points following their release from alpha factor. (C, D) The percentage of Rad52-GFP foci in the indicated cells harvested as shown in (A). (E) Cells harvested, as shown in Figure 2A, were analyzed for cell viability using PI staining. Representative images show PI-positive cells (dead cell, arrow) and PI-negative cells (live cell, arrowhead). The percentage of dead cells with or without MMS treatment for 90 min is graphically shown. At least 250 cells were analyzed for each set in (C, D), and (E) from three independent experiments. Error bars represent the standard error of the mean. The p-values were determined by an unpaired two-tailed Student’s t-test. Scale bar = 2 µm. Figure 2—figure supplement 2—source data 1.Source data for Figure 2—figure supplement 2. Source data for Figure 2—figure supplement 2. To understand the dynamics of Rad52 foci formation in Scm3-depleted cells, we used an alpha factor arrest and release (Figure 2—figure supplement 2A). Briefly, bar1∆ RAD52-GFP SCM3-AID cells were arrested in the G1 phase of the cell cycle by adding alpha factor. 1 hr before release from G1 phase, cells were treated with auxin to deplete Scm3 or with the solvent DMSO as control. Subsequently, cells were washed and released into alpha factor-free media with or without MMS with either DMSO or auxin and with nocodazole to have all cells eventually arrest at metaphase. Following the alpha factor release, cells were harvested every 30 min and the percentage of cells containing Rad52-GFP foci was determined (Figure 2—figure supplement 2B). Without MMS, Scm3-depleted cells, but not the wild type, showed a peak of Rad52-GFP accumulation at around 60 min after G1 release (Figure 2—figure supplement 2C). Notably, this time point coincides with the timing of DNA replication (judged by bud morphology) when DNA is most susceptible to damage. In the presence of MMS, both cells with or without auxin showed a peak of Rad52-GFP accumulation at 60 min after release, but the fraction of cells with Rad52-GFP foci was higher when auxin was present, that is Scm3 depleted (Figure 2—figure supplement 2D). Taken together, Scm3-depleted cells exhibit more Rad52 foci, indicating a compromised DDR pathway in these cells. However, defects in DNA replication or the creation of other DNA lesions producing more foci cannot be ruled out. If the DNA lesions remain unrepaired, the cells might undergo an apoptotic pathway leading to cell death. To determine the percentage of cell death, we conducted an experiment as outlined in Figure 2A and stained with propidium iodide (PI), which does not permeate live cells and stains only dead cells (Figure 2—figure supplement 2E, arrow). We observed that ~15% of the Scm3-depleted (+auxin, -MMS) cells were PI positive, in contrast to only ~4% for the wild type (DMSO, -MMS; Figure 2—figure supplement 2E, untreated). The PI-positive cell population increased after MMS treatment in both cultures, with a significant difference between them (35% vs 27%; Figure 2—figure supplement 2, 0.02% MMS). These results suggest that DNA damage in the absence of Scm3 leads to compromised cell viability. Scm3 associates with non-centromeric sites in response to DNA damage Having observed that Scm3-depleted cells accumulate DNA damage and that Scm3-depleted cells interact genetically with rad52D, we hypothesized that Scm3 may be recruited to DNA damage sites. To examine this, we first wanted to see if Scm3 alters its localization pattern in response to MMS-mediated DNA damage. Since Scm3 is also expected to localize at the kinetochores (Mizuguchi et al., 2007), we visualized Scm3 along with the kinetochore marker, Ndc10, on chromatin spreads. Cells harboring NDC10-6HA SCM3-13MYC were mock-treated or treated with 0.02% MMS for 90 min. Ndc10 showed bright foci representing the kinetochore cluster, whereas Scm3 was localized to multiple locations across chromatin, including colocalizing with Ndc10 (Figure 3A, arrow). A similar localization of Scm3 throughout the nucleus has been observed earlier in live cells (Luconi et al., 2011; Wisniewski et al., 2014). We also observed a significant enrichment of Scm3 at the rDNA loops irrespective of the exogenous DNA damage (Figure 3A, arrowhead). The enrichment of Scm3 at the rDNA loops may reflect a role in maintaining the highly repetitive organization of rDNA. HJURP has also been shown to localize to rDNA arrays in mammalian systems (Kato et al., 2007). Additionally, upon quantifying the total intensity of Scm3-13Myc and Ndc10-6HA normalized against the background intensity, we observed a statistically significant increase in Scm3-13Myc, but not Ndc10-6HA intensity in response to MMS treatment (Figure 3B and C). No change in the intensity of Ndc10-6HA post-MMS treatment is consistent with the absence of MMS sensitivity in Ndc10-depleted cells (Figure 1—figure supplement 3A). Localization of Scm3 in response to DNA damage. (A) Representative images showing the localizations of Ndc10-6HA and Scm3-13Myc using chromatin spreads. The mid-log grown NDC10-6HA SCM3-13MYC cells were treated with 0.02% MMS or mock-treated for 90 min prior to imaging. The arrows show the co-localization of Ndc10-6HA and Scm3-13Myc at the kinetochore cluster, and the arrowhead shows the rDNA loop. Scale bar = 2 µm. (B) The intensities of Scm3-13Myc and Ndc10-6HA after subtracting background intensity were quantified and plotted. (C) Mean values from three independent experiments. At least 30 spreads were analyzed for each set, as shown in (B). The p-values were determined by unpaired two-tailed student’s t-test. (D) Whole genome view of the enriched peaks at the centromeric and non-centromeric regions in cells treated with 0.02% MMS or mock-treated. (E) Representative snapshot of chromosome XII, showing the peaks in the input and the samples (Scm3 IP). In the sample tracks (MMS-treated or mock-treated), the corresponding input signal is overlapped on the sample signal to clearly show the enrichment at the peaks. Figure 3—source data 1.Source data for Figure 3. Source data for Figure 3. Figure 3—figure supplement 1.Analysis of non-centromeric binding sites (peaks) of Scm3.(A)SCM3-6HA cells were grown till mid-log and were treated with MMS or left untreated for 90 min following nocodazole treatment. The cells were harvested and analyzed for DAPI staining and bud morphology to visualize the cell cycle stages. Scale bar = 2 µm. (B) The peak statistics and (C) features within the peaks in MMS-treated and untreated samples from Figure 3. The GO term analysis of the non-centromeric peaks from (D) MMS-treated or (E) untreated samples (X axis: Gene count, Y axis: GO terms). (F) The motifs observed in the non-centromeric peaks from MMS-treated and untreated samples. Analysis of non-centromeric binding sites (peaks) of Scm3. (A)SCM3-6HA cells were grown till mid-log and were treated with MMS or left untreated for 90 min following nocodazole treatment. The cells were harvested and analyzed for DAPI staining and bud morphology to visualize the cell cycle stages. Scale bar = 2 µm. (B) The peak statistics and (C) features within the peaks in MMS-treated and untreated samples from Figure 3. The GO term analysis of the non-centromeric peaks from (D) MMS-treated or (E) untreated samples (X axis: Gene count, Y axis: GO terms). (F) The motifs observed in the non-centromeric peaks from MMS-treated and untreated samples. Having observed an increased chromatin localization of Scm3 in response to MMS on chromatin spreads, we wished to verify this by determining the genome-wide association of Scm3 using ChIP-Seq. To rule out any cell cycle differences that may influence Scm3 DNA binding, we first arrested the cells harboring SCM3-13MYC at metaphase with nocodazole. The arrested cells were further mock-treated or treated with 0.05% MMS for an additional 90 min before they were harvested for ChIP. Both the MMS-treated and untreated samples were similarly arrested as judged by DAPI staining (Figure 3—figure supplement 1A). The Scm3 ChIP-seq signal was normalized with the input signal, and genome-wide plots were generated to see Scm3 binding along the entire chromosomes. We also performed ChIP-seq from a no-tag control strain that provided the background signal from unspecific interactions with the antibody or beads. The Scm3 ChIP-seq signal was normalized with the input signal, and upon quantification from MACS2, we observed the enrichment (peaks) of Scm3 at all 16 centromeres in both untreated and MMS-treated samples (Figure 3D, blue bars). Scm3 was also enriched at the 9.1 kb rDNA region on Chr XII in both untreated and treated samples (Figure 3E, at rDNA), consistent with our chromatin spread data (Figure 3A). Upon further analysis, the enrichment of Scm3 at rDNA, which harbors repetitive regions, was found to be ~1.4-fold in the treated cells (1.54-fold enrichment relative to input) compared to untreated cells (1.06-fold enrichment relative to input; Figure 3E), suggesting its general preference towards such regions. Besides the centromeric peaks, 17 non-centromeric peaks (~1.4–1.8-fold enrichment over input) were detected in untreated samples, compared to 75 peaks (~1.3–1.9-fold enrichment over input) in MMS-treated cells, in which only two peaks were shared (Figure 3—figure supplement 1B). This analysis clearly demonstrates an increase in the binding of Scm3 to the non-centromeric sites upon MMS treatment. The feature analysis of these sites revealed that MMS-treated samples were enriched in peaks which comprise fragile sites (Song et al., 2014) and recombination hotspots (Gerton et al., 2000), which are prone to DNA damage. The untreated samples had a comparatively smaller number of such damage-prone sites (Figure 3—figure supplement 1C, fragile sites and hotspots). Moreover, the MMS-treated samples had a higher number of peaks with short tandem repeats (length 5–7 nucleotides), interspersed repeats, and low complexity regions (less diversity of nucleotides) than in the untreated samples. These repeat regions are also shown to be a source of DNA damage, as they form alternative non-B DNA structures, which are more prone to damage (Brown and Freudenreich, 2021; Wierdl et al., 1997). Furthermore, analysis of the gene ontology (GO) associated with the 17 non-centromeric peaks revealed GO terms that are involved in normal metabolic pathways such as glycolysis/gluconeogenesis, regulation of amino acids, and telomere maintenance (Figure 3—figure supplement 1E) while in the treated samples the 75 non-centromeric peaks had GO terms that are mostly related to nucleotide synthesis and detoxification/flocculation, which are usually triggered in stress conditions (Figure 3—figure supplement 1D). We speculate that Scm3 might bind to these genes to ameliorate the DNA damage stress caused by MMS treatment. Hence, we could attribute the increased binding of the Scm3 to the non-centromeric regions to DNA damage. To further understand the nature of the non-centromeric sites harboring the enriched peaks (17 untreated, 75 treated), they were scanned for the presence of any motifs, and we observed three and one significant motifs in the treated and in the untreated samples, respectively (Figure 3—figure supplement 1F). The three motifs in the MMS-treated samples were specifically observed in the viral LTR region of the gag-pol fusion gene, based on the annotation from the NCBI reference genome (NCBI accession: GCF_000146045.2). These viral LTRs are found in multiple chromosomes spanning 29 peaks (~39% of total peaks) in the treated samples. Interestingly, these regions are considered fragile sites marked by the binding of Rrm3 helicase (Song et al., 2014). Notably, these viral LTRs are also known to trigger DNA-damage response pathways (Sinclair et al., 2006). This suggests that upon DNA damage induction, Scm3 is recruited to genomic locations that are more prone to damage. Scm3 partially co-localizes with Rad52, perhaps at the DNA damage sites Given the increased chromatin association of Scm3 in response to DNA damage, we wished to investigate if this occurs due to its binding to DNA damage sites. For this, we examined the colocalization of Scm3 with Rad52 upon DNA damage, as the latter is known to be targeted to the damage sites (Lisby et al., 2003; Miyazaki et al., 2004). Cells harboring RAD52-6HA and SCM3-13MYC were mock-treated or treated with 0.02% MMS for 90 min. We did not observe a significant co-localization between Scm3-13Myc and Rad52-6HA in untreated cells as judged by low Pearson’s Correlation Coefficient value (PCC <0.4; Figure 4A–C). However, in the cells treated with MMS, we could observe a significant increase in the PCC value (PCC >0.45; Figure 4B–C). This indicates a partial co-localization between Scm3 and Rad52 in the presence of the DNA damage and implies that Scm3 may localize to the damage sites in response to DNA damage. Scm3 colocalizes with DDR proteins in response to DNA damage. (A) Representative images showing the localizations of Rad52-6HA and Scm3-13Myc using chromatin spreads. The mid-log grown RAD52-6HA SCM3-13MYC cells were treated with 0.02% MMS or mock-treated for 90 min prior to imaging. (B) Quantification of the colocalization between Rad52-6HA and Scm3-13Myc using Pearson’s correlation coefficient (PCC). (C) Mean values from three independent experiments. (D) Representative images showing the localizations of γ-H2A and Scm3-13Myc using chromatin spreads. The mid-log grown SCM3-MYC cells were treated with 0.02% MMS or mock-treated for 90 min prior to imaging. (E) Quantification of the colocalization between γ-H2A and Scm3-13Myc using PCC. (F) Mean values from three independent experiments. At least 30 spreads from three independent experiments were analyzed for each set in (B) and (E). The p-values were determined by unpaired two-tailed student’s t-test. Scale bar = 2 µm. Figure 4—source data 1.Source data for Figure 4. Source data for Figure 4. Figure 4—figure supplement 1.Localization of proteins in presence or absence of DNA damage.(A) Representative images showing the localization of γ-H2A using chromatin spreads. The mid-log grown wild type cells were treated with 0.02% MMS or mock-treated for 90 min prior to imaging. (B) The intensities of γ-H2A after subtracting background intensity were quantified and plotted. (C) Mean values from three independent experiments. (D) Representative images showing the localizations of γ-H2A and Rad52-6HA using chromatin spreads. The mid-log grown RAD52-6HA cells were treated with 0.02% MMS or mock-treated for 90 min prior to imaging. (E) Quantification of the co-localization between γ-H2A and Rad52-6HA was estimated using Pearson’s correlation coefficient (PCC). (F) Mean values from three independent experiments. (G) Representative images showing the localization of γ-H2A and Scm3-13Myc using chromatin spreads after rotating the γ-H2A image by 180° from Figure 4D. (H) Quantification of the co-localization between γ-H2A and Scm3-13Myc was estimated using Pearson’s correlation coefficient (PCC). (I) Mean values from three independent experiments. (J) Representative images showing the localization of γ-H2A and Scm3-13Myc using chromatin spreads. Wild type or sml1∆mec1∆tel1∆ cells were grown till mid-log and treated with 0.02% MMS for the assay. (K) The intensity of Scm3-13Myc subtracting with the background in the indicated strains was quantified and plotted. (L) Mean values from three independent experiments. At least 30 spreads were analyzed for each set in (B), (E), (H), and (K) from three independent experiments. The p values were determined by unpaired two-tailed student’s t-test. Scale bar = 2 µm. Figure 4—figure supplement 1—source data 1.Source data for Figure 4—figure supplement 1. Localization of proteins in presence or absence of DNA damage. (A) Representative images showing the localization of γ-H2A using chromatin spreads. The mid-log grown wild type cells were treated with 0.02% MMS or mock-treated for 90 min prior to imaging. (B) The intensities of γ-H2A after subtracting background intensity were quantified and plotted. (C) Mean values from three independent experiments. (D) Representative images showing the localizations of γ-H2A and Rad52-6HA using chromatin spreads. The mid-log grown RAD52-6HA cells were treated with 0.02% MMS or mock-treated for 90 min prior to imaging. (E) Quantification of the co-localization between γ-H2A and Rad52-6HA was estimated using Pearson’s correlation coefficient (PCC). (F) Mean values from three independent experiments. (G) Representative images showing the localization of γ-H2A and Scm3-13Myc using chromatin spreads after rotating the γ-H2A image by 180° from Figure 4D. (H) Quantification of the co-localization between γ-H2A and Scm3-13Myc was estimated using Pearson’s correlation coefficient (PCC). (I) Mean values from three independent experiments. (J) Representative images showing the localization of γ-H2A and Scm3-13Myc using chromatin spreads. Wild type or sml1∆mec1∆tel1∆ cells were grown till mid-log and treated with 0.02% MMS for the assay. (K) The intensity of Scm3-13Myc subtracting with the background in the indicated strains was quantified and plotted. (L) Mean values from three independent experiments. At least 30 spreads were analyzed for each set in (B), (E), (H), and (K) from three independent experiments. The p values were determined by unpaired two-tailed student’s t-test. Scale bar = 2 µm. Figure 4—figure supplement 1—source data 1.Source data for Figure 4—figure supplement 1. Source data for Figure 4—figure supplement 1. Figure 4—figure supplement 2.Hsf1 does not co-localize with γ-H2A in response to MMS or heat shock.(A) Representative images showing the localization of Hsf1-13Myc using chromatin spread. (B) Box plots showing the number of Hsf1-13Myc foci per nuclear spread in cells treated at 37 °C for 15 min or untreated. (C) Mean values from three independent experiments. (D) Representative images showing the localization of γ-H2A and Hsf1-13Myc using chromatin spreads. The mid-log grown HSF1-13MYC cells were treated with 0.02% MMS or mock-treated for 90 min or given heat shock at 37 °C for 15 min prior to imaging. (E) Quantification of the co-localization between γ-H2A and Hsf1-13Myc was estimated using Pearson’s correlation coefficient (PCC). (F) Mean values from three independent experiments. At least 30 spreads were analyzed for each set in (B) and (E), from three independent experiments. The p values were determined by unpaired two-tailed student’s t-test. Scale bar = 2 µm. Figure 4—figure supplement 2—source data 1.Source data for Figure 4—figure supplement 2. Hsf1 does not co-localize with γ-H2A in response to MMS or heat shock. (A) Representative images showing the localization of Hsf1-13Myc using chromatin spread. (B) Box plots showing the number of Hsf1-13Myc foci per nuclear spread in cells treated at 37 °C for 15 min or untreated. (C) Mean values from three independent experiments. (D) Representative images showing the localization of γ-H2A and Hsf1-13Myc using chromatin spreads. The mid-log grown HSF1-13MYC cells were treated with 0.02% MMS or mock-treated for 90 min or given heat shock at 37 °C for 15 min prior to imaging. (E) Quantification of the co-localization between γ-H2A and Hsf1-13Myc was estimated using Pearson’s correlation coefficient (PCC). (F) Mean values from three independent experiments. At least 30 spreads were analyzed for each set in (B) and (E), from three independent experiments. The p values were determined by unpaired two-tailed student’s t-test. Scale bar = 2 µm. Figure 4—figure supplement 2—source data 1.Source data for Figure 4—figure supplement 2. Source data for Figure 4—figure supplement 2. Next, we wished to examine the behavior of Scm3 with respect to another DNA damage marker. In mammals, the DSB sites are marked by γ-H2Ax, which also goes to other chromosomal locales, due to ATM/ATR kinases mediated phosphorylation of the H2A variant, H2Ax (Burma et al., 2001; Lee et al., 2014). In yeast, which lacks H2Ax, the DSBs are marked by γ-H2A due to phosphorylation of histone H2A by Mec1 and Tel1 kinases (Lee et al., 2014). Notably, γ-H2A is also found at the heterochromatin region and co-localizes with the yeast heterochromatin protein Sir3 (Javaheri et al., 2006; Kirkland et al., 2015; Kitada et al., 2011). We performed a chromatin spread assay using antibodies specific to γ-H2A and observed a drastic increase in the intensity of γ-H2A when the cells were subjected to DNA damage, which is expected (Figure 4—figure supplement 1A–C). To verify that the phenomenon is associated with DNA damage, we observed a significant increase in the colocalization between Rad52 and γ-H2A in response to DNA damage (Figure 4—figure supplement 1D–F). To further correlate the localization of Scm3 with DNA damage, we then visualized both Scm3-13Myc and γ-H2A simultaneously on chromatin spreads from SCM3-13MYC cells mock-treated or treated with 0.02% MMS for 90 min. We did not observe any significant co-localization between Scm3-13Myc and γ-H2A in untreated cells as judged by low Pearson’s Correlation Coefficient value (PCC <0.3) but found a significant increase in the value (PCC >0.5) in MMS-treated cells (Figure 4D–F). We verified the accuracy of the assay by rotating the red and green fluorescence images through 180° relative to each other and recalculating the PCC value as described earlier (Ma et al., 2023). After rotation, we failed to observe any significant correlation between Scm3-13Myc and γ-H2A (Figure 4—figure supplement 1G–I), suggesting the observed high PCC values (Figure 4D–F) are not an artifact of the assay. In order to negate the possibility that the increased co-localization of Scm3-6HA with Rad52 or γ-H2A following MMS treatment is merely due to the increased accumulation of the DDR proteins in response to MMS within the small yeast nucleus, we tested the colocalization of an unrelated transcription factor, Hsf1, with γ-H2A. Since Hsf1 is known to increase its chromatin association in response to heat shock (Chowdhary et al., 2019; Rubio et al., 2024), we verified this by incubating the cells at 37 °C for 15 min. As expected, Hsf1 showed an increased chromatin association (a greater number of Hsf1-13Myc foci) at high temperatures compared to normal temperatures (Figure 4—figure supplement 2A–C). As expected, the increased chromatin occupancy of Hsf1 or γ-H2A due to high temperature or MMS treatment, respectively, did not result in any significant increase in the co-localization frequency between the two proteins (Figure 4—figure supplement 2D–F). Taken together, we conclude that the association of Scm3 with chromatin and its co-localization with DDR proteins increases with DNA damage. Since we observed high co-localization between Scm3-13Myc and γ-H2A in MMS-treated cells (Figure 4D), we wished to understand if the localization of Scm3 is dependent on γ-H2A. For this, we performed chromatin spread assay to visualize the behavior of Scm3 in the mec1∆ tel1∆ double mutant, where γ-H2A remains absent on the chromatin at the DSB sites. As expected, we observed a drastic drop in γ-H2A localization on the spreads in the double mutant as compared to wild-type cells in MMS--treated samples, which validates the assay. Upon quantification of the total intensity of Scm3 and normalizing that with the background intensity, we did not observe any statistically significant drop in the localization of Scm3 on the chromatin (Figure 4—figure supplement 1J–L). This suggests that the recruitment of Scm3 at the damage sites is not influenced by prior localization of γ-H2A at those sites. Scm3 is recruited to a site-specific DSB The overall increased association of Scm3 with chromatin and its colocalization with Rad52 and γ-H2A in response to MMS-mediated DNA damage prompted us to examine if Scm3 is recruited specifically to DNA damage sites. For this, we utilized the chromatin immunoprecipitation (ChIP) assay to visualize the dynamics of Scm3 recruitment at an induced DSB site. We used a yeast strain (NA14) harboring an HO cut site integrated at the mutant ura3 locus, which is cleavable by HO endonuclease upon galactose induction (Agmon et al., 2009; Fangaria et al., 2022). The strain also contains a distant URA3 locus, which is utilized to repair the cut ura3 locus post-DSB induction. The cleavage by HO endonuclease was first verified by PCR-based analysis using primers complementary to the DNA sequence flanking the HO cut site (Figure 5A). The DNA damage was maximal at 2 hr of galactose induction, and the damage was majorly repaired by 4 hr of galactose induction (Figure 5—figure supplement 1A–B). Scm3 is recruited to a site-specific double-stranded break (DSB). (A) Schematic representation of the HO endonuclease cut site (HOcs) integrated at the URA3 locus in the NA14 strain. Upon galactose induction, the HO endonuclease cleaves the DNA at the specific site, generating a DSB. The positions of the primers (OSB289 and kanB1), used to detect the DSB, are shown along with primers to detect binding of Scm3 near and distal (−1 to –3 kb) to the DSB (B) ChIP analyses were performed to quantify the association of Scm3-6HA in the NA14 strain. The PCR-amplified DNA bands following ChIP were run on an agarose gel and stained with ethidium bromide. (C) ChIP analyses for measuring the association of Scm3-6HA with the indicated loci were performed at the indicated time points of HO induction. The ChIP efficiency as percentage enrichment per input obtained by qPCR analysis of the immunoprecipitated DNA is plotted. (D) The same analysis as in (C) using no antibody (-Ab) control. Error bars represent the standard error of the mean. The p-values in (C) and (D) were determined by two-way ANOVA test followed by Dunnett’s multiple comparison test from two independent experiments. Figure 5—source data 1.Original files for gels displayed in Figure 5B. Original files for gels displayed in Figure 5B. Figure 5—source data 2.Original files for gels displayed in Figure 5B indicating relevant bands. Original files for gels displayed in Figure 5B indicating relevant bands. Figure 5—source data 3.Source data for Figure 5. Source data for Figure 5. Figure 5—figure supplement 1.Dynamics of HO-induced DSB formation and protein binding at centromere and DSB sites.(A) NA14 yeast cells were grown till mid-log in 3% glycerol, following which galactose was added for HO induction. Cells were harvested at indicated time points, and genomic DNA was extracted. PCR was performed to get the band (DSB) to estimate the extent of DNA damage using the primers OSB289 and kanB1, as shown in Figure 4A. PCR was also performed using primers against TUB2 ORF as a loading control band (Tubulin). (B) The intensity of the DSB band normalized with the tubulin band in (A) was quantified using ImageJ software. The value at 0 hr was taken as 100% DSB band remaining (uncut), and accordingly, the % uncut DNA remaining for other time points was calculated. (C) ChIP analyses for measuring the association of Scm3-6HA and Rad51 with the CEN3 locus were performed at the indicated time points of HO induction. (D) ChIP analyses for measuring the association of Scm3-6HA at the CEN3 and TUB2 loci (E) were performed at the indicated time points of HO induction. (F) ChIP analyses for measuring the association of Rad51 with the indicated loci were performed at the indicated time points of HO induction. Error bars represent the standard error of the mean. The p values in (F) were determined by a two-way ANOVA test followed by Dunnett’s multiple comparison test from two independent experiments. Figure 5—figure supplement 1—source data 1.Original files for gels displayed in Figure 5—figure supplement 1A. Figure 5—figure supplement 1—source data 2.Original files for gels displayed in Figure 5—figure supplement 1A indicating relevant bands. Figure 5—figure supplement 1—source data 3.Source data for Figure 5—figure supplement 1. Dynamics of HO-induced DSB formation and protein binding at centromere and DSB sites. (A) NA14 yeast cells were grown till mid-log in 3% glycerol, following which galactose was added for HO induction. Cells were harvested at indicated time points, and genomic DNA was extracted. PCR was performed to get the band (DSB) to estimate the extent of DNA damage using the primers OSB289 and kanB1, as shown in Figure 4A. PCR was also performed using primers against TUB2 ORF as a loading control band (Tubulin). (B) The intensity of the DSB band normalized with the tubulin band in (A) was quantified using ImageJ software. The value at 0 hr was taken as 100% DSB band remaining (uncut), and accordingly, the % uncut DNA remaining for other time points was calculated. (C) ChIP analyses for measuring the association of Scm3-6HA and Rad51 with the CEN3 locus were performed at the indicated time points of HO induction. (D) ChIP analyses for measuring the association of Scm3-6HA at the CEN3 and TUB2 loci (E) were performed at the indicated time points of HO induction. (F) ChIP analyses for measuring the association of Rad51 with the indicated loci were performed at the indicated time points of HO induction. Error bars represent the standard error of the mean. The p values in (F) were determined by a two-way ANOVA test followed by Dunnett’s multiple comparison test from two independent experiments. Figure 5—figure supplement 1—source data 1.Original files for gels displayed in Figure 5—figure supplement 1A. Original files for gels displayed in Figure 5—figure supplement 1A. Figure 5—figure supplement 1—source data 2.Original files for gels displayed in Figure 5—figure supplement 1A indicating relevant bands. Original files for gels displayed in Figure 5—figure supplement 1A indicating relevant bands. Figure 5—figure supplement 1—source data 3.Source data for Figure 5—figure supplement 1. Source data for Figure 5—figure supplement 1. Figure 5—figure supplement 2.DSB repair is delayed in the absence of Scm3.(A) NA14 yeast cells harboring SCM3-AID degron allele were grown till mid-log in 3% glycerol in the presence of DMSO (wild type), or auxin (Scm3 depleted), following which galactose was added for HO induction. Cells were harvested at the indicated time points, and genomic DNA was extracted. PCR was performed to get the band (DSB) to estimate the extent of DNA damage using the primers OSB289 and kanB1, as shown in Figure 4A. PCR was also performed using primers against TUB2 ORF as a loading control band (Tubulin). (B) The intensity of the DSB band normalized with the tubulin band in (A) was quantified using ImageJ software. The value at 0 hr was taken as 100% DSB band remaining (uncut), and accordingly, the % uncut DNA remaining for other time points was calculated. Figure 5—figure supplement 2—source data 1.Original files for gels displayed in Figure 5—figure supplement 2A. Figure 5—figure supplement 2—source data 2.Original files for gels displayed in Figure 5—figure supplement 2A indicating relevant bands. Figure 5—figure supplement 2—source data 3.Source data for Figure 5—figure supplement 2. DSB repair is delayed in the absence of Scm3. (A) NA14 yeast cells harboring SCM3-AID degron allele were grown till mid-log in 3% glycerol in the presence of DMSO (wild type), or auxin (Scm3 depleted), following which galactose was added for HO induction. Cells were harvested at the indicated time points, and genomic DNA was extracted. PCR was performed to get the band (DSB) to estimate the extent of DNA damage using the primers OSB289 and kanB1, as shown in Figure 4A. PCR was also performed using primers against TUB2 ORF as a loading control band (Tubulin). (B) The intensity of the DSB band normalized with the tubulin band in (A) was quantified using ImageJ software. The value at 0 hr was taken as 100% DSB band remaining (uncut), and accordingly, the % uncut DNA remaining for other time points was calculated. Figure 5—figure supplement 2—source data 1.Original files for gels displayed in Figure 5—figure supplement 2A. Original files for gels displayed in Figure 5—figure supplement 2A. Figure 5—figure supplement 2—source data 2.Original files for gels displayed in Figure 5—figure supplement 2A indicating relevant bands. Original files for gels displayed in Figure 5—figure supplement 2A indicating relevant bands. Figure 5—figure supplement 2—source data 3.Source data for Figure 5—figure supplement 2. Source data for Figure 5—figure supplement 2. We monitored the recruitment of Scm3 near DSB and at sites distal to that up to –3 kb away (Figure 5A) by performing ChIP of Scm3-6HA from the samples collected at every hr up to 4 hr following galactose induction. As a positive control for Scm3 ChIP, we found significant enrichment of Scm3 at the centromere (CEN3; Figure 5—figure supplement 1C). We observed a significant increase in the Scm3 binding near the DSB at 2 hr of galactose induction and a decrease in the enrichment at 4 hr, possibly due to the gradual repair of the damage (Figure 5B–C). We also observed an increase in the enrichment of Scm3 up to –3 kb distal to the cut site, which decreased gradually over time (Figure 5C) and no significant enrichment at the TUB2 locus, used as negative control (Figure 5C) or in the no antibody control (Figure 5D). This suggests that Scm3 is maximally recruited to the cleavage sites at the time of DNA damage and gradually dissociates when the DNA is repaired. To confirm that the enrichment of Scm3 at 2 hr at the HO-induced DSB sites is a site-specific response rather than a global chromatin enrichment, we verified the enrichment of Scm3-6HA at the CEN3 and TUB2 loci at different time points of HO induction. We could not observe any significant enrichment of Scm3 at those loci over different time points, suggesting Scm3 specifically enriches at the DSB sites upon DNA damage (Figure 5—figure supplement 1D, E). To verify that the HO-induced DSB can recruit DNA repair proteins, we also investigated the enrichment of one such protein, Rad51, which is known to bind DSB sites (Fangaria et al., 2022). We found Rad51 maximally enriched at the DSB site 2–3 hr after galactose induction (Figure 5—figure supplement 1F). We conclude that upon DNA damage, Scm3 associates with the damage sites and may act in cis to facilitate damage repair. We postulate that the association of Scm3 at the DSB site is to facilitate DNA damage repair. In that case, we expect to observe an altered kinetics of repair in the absence of Scm3. To examine this, we constructed the SCM3-AID allele in the NA14 background and released the cells in galactose (for HO induction and DNA cleavage) after treating them with DMSO (wild type) or auxin (Scm3-depleted). Cells were harvested at different time points, as mentioned earlier, and the extent of DNA damage and DNA repair was monitored using primers flanking the HO cut site (Figure 5A). While in the wild type, the DSB is repaired by 55% by 4 hr and is completed by 6 hr, the Scm3-depleted cells showed a delay in the DSB repair, which was only 15% by 4 hr time point and reaches a maximum of 65% by 6 hr time point (Figure 5—figure supplement 2A, B). This delay in repair is independent of the cell cycle delay mediated by Scm3 depletion, as cells arrested at metaphase also show significant repair in G2/M stage of the cell cycle (Aylon et al., 2004). This result suggests that Scm3 at the DSB site aids in the repair of the DNA damage, perhaps by interacting with the DDR proteins (Figure 4). Activation of the DDR checkpoint is perturbed in the scm3 mutant Having shown the recruitment of Scm3 at the DNA damage sites and the observation that Scm3-depleted cells are compromised in repairing DNA damage, we wished to understand if Scm3 being at the damage sites activates the DDR checkpoint, which is required for damage repair. In the DDR pathway, Rad53 is an effector kinase that becomes phosphorylated in a Mec1 sensor kinase-dependent manner in response to DNA damage (Ciccia and Elledge, 2010; Melo and Toczyski, 2002; Zhou and Elledge, 2000). The phosphorylation of Rad53 is essential to halt the cell cycle and provide cells with time to repair damaged DNA. To examine whether Scm3-depleted cells have defects in the activation of DDR checkpoint and in halting the cell cycle, we measured Rad53 phosphorylation in SCM3-AID cells in the presence or absence of auxin after treating them with 0.02% MMS for 90 min (Figure 6—figure supplement 1A). Anti-Rad53 antibodies that recognize both phosphorylated and unphosphorylated forms of Rad53 were used. We observed lesser phosphorylation of Rad53 in Scm3-depleted cells (SCM3-AID+auxin) as compared to SCM3-AID cells (Figure 6—figure supplement 1B–C). Since Scm3-depleted cells, unlike the wild type, arrest at the G2/M stage due to activation of spindle assembly checkpoint (SAC) (Camahort et al., 2007; Stoler et al., 2007), the observed difference in Rad53 phosphorylation could be due to the difference in cell cycle stages. To circumvent this issue, we grew CDC20-AID and SCM3-AID cells for 3 hr before treating them with 0.75 mM auxin for 2 hr to arrest them at G2/M by depleting Cdc20 and Scm3, respectively (Figure 6A). The cells were then treated with 0.02% MMS and harvested at indicated time points for total protein extraction. The CDC20-AID and SCM3-AID cultures showed around ~80% metaphase arrest cells after 2 hr of auxin treatment (0 min in Figure 6—figure supplement 1D). Notably, while the Cdc20-depleted cells maintained the arrest even with a longer incubation in auxin, the Scm3-depleted cells tended to bypass the arrest after a certain time and showed accumulation of multibudded cells with fragmented DAPI, an arrest-release phenotype (Figure 6—figure supplement 1E, Figure 6C). Consistent with our previous results (Figure 6—figure supplement 1B–C), we observed that in SCM3-AID+auxin cells, Rad53 was less phosphorylated than in CDC20-AID+auxin cells (Figure 6B). Since Scm3-depleted cells showed reduced Rad53 phosphorylation, we wished to examine if the lack of Scm3 perturbs Mec1 kinase function, which phosphorylates Rad53. Mec1 also phosphorylates histone H2A at S129 upon DNA damage (Lee et al., 2014). However, we failed to observe any significant difference in the phosphorylation status of H2AS129 between Scm3- or Cdc20-depleted cells (Figure 6—figure supplement 1F), indicating that Mec1 function is not perturbed in the absence of Scm3. These results indicate that in the absence of Scm3, when there is DNA damage, the activation of the DDR checkpoint is improper, and consequently, the phosphorylation of Rad53 is compromised. Evidence of a DNA damage checkpoint defect in the absence of Scm3. (A) Schematic of the experimental strategy to detect Rad53 in Scm3- or Cdc20-depleted cells treated with MMS for different time points. (B) Western blots from indicated cells according to the protocol in (A). (C) mad2∆, SCM3-AID, and SCM3-AID mad2∆ cells were first treated with 0.75 mM auxin for 2 hr to deplete Scm3 and then either treated with 0.02% MMS for 90 min or left untreated. The cells were harvested and scored for the presence of multibudded cells (shown on the left). At least 150 cells from three independent experiments were analyzed for each set. Error bars represent the standard error of the mean. The p-values were determined by a one-way ANOVA test followed by Tukey’s multiple comparison test. Scale bar = 2 µm. (D) Schematic of the experimental strategy to detect Pds1 in mad2∆ SCM3-AID cells in the presence of DMSO or auxin (Scm3-depleted) and each treated with 0.02% MMS for different time points. (E) Western blot showing Pds1 and TIR1 (as loading control). Cells were harvested following the strategy given in (D). (F) The intensities of the Pds1 measured by ImageJ were plotted after normalizing with the corresponding loading control (TIR1). (G) The percentage of anaphase cells judged by DAPI staining and bud morphology for each time point of cells harvested in (D) is presented graphically. Figure 6—source data 1.Original files for western blot analysis displayed in Figure 6B and E. Original files for western blot analysis displayed in Figure 6B and E. Figure 6—source data 2.Original files for western blot analysis displayed in Figure 6B and E indicating relevant bands. Original files for western blot analysis displayed in Figure 6B and E indicating relevant bands. Figure 6—source data 3.Source data for Figure 6. Source data for Figure 6. Figure 6—figure supplement 1.H2A phosphorylation is not perturbed in the absence of Scm3.(A) The schematic of the experimental strategy that was followed for detecting Rad53 in SCM3-AID cells in the presence of DMSO (wild-type) or auxin (Scm3 depleted) and each either treated with MMS or left untreated. (B) Western blots showing p-Rad53/Rad53 and tubulin (as loading control) from indicated cells obtained from (A). (C) Loading control normalized intensities of the p-Rad53 were quantified and plotted. Error bars represent the standard error of the mean. The p-values were determined by an unpaired t-test. (D) CDC20-AID or SCM3-AID strains were grown till mid-log and treated with 0.75 mM auxin for depletion of Cdc20 or Scm3, respectively. The cells were then treated with MMS for 240 min, and samples were harvested at the indicated time points. The percentage of metaphase cells judged by DAPI staining and bud morphology for each time point is presented graphically. (E) The percentage of multibudded cells in the samples harvested in (D) is presented. (F) Western blots showing γ-H2A and tubulin (as loading control). Cells were harvested following the strategy given in Figure 6A. Figure 6—figure supplement 1—source data 1.Original files for western blot analysis displayed in Figure 6—figure supplement 1B, F. Figure 6—figure supplement 1—source data 2.Original files for western blot analysis displayed in Figure 6—figure supplement 1B, F indicating relevant bands. Figure 6—figure supplement 1—source data 3.Source data for Figure 6—figure supplement 1. H2A phosphorylation is not perturbed in the absence of Scm3. (A) The schematic of the experimental strategy that was followed for detecting Rad53 in SCM3-AID cells in the presence of DMSO (wild-type) or auxin (Scm3 depleted) and each either treated with MMS or left untreated. (B) Western blots showing p-Rad53/Rad53 and tubulin (as loading control) from indicated cells obtained from (A). (C) Loading control normalized intensities of the p-Rad53 were quantified and plotted. Error bars represent the standard error of the mean. The p-values were determined by an unpaired t-test. (D) CDC20-AID or SCM3-AID strains were grown till mid-log and treated with 0.75 mM auxin for depletion of Cdc20 or Scm3, respectively. The cells were then treated with MMS for 240 min, and samples were harvested at the indicated time points. The percentage of metaphase cells judged by DAPI staining and bud morphology for each time point is presented graphically. (E) The percentage of multibudded cells in the samples harvested in (D) is presented. (F) Western blots showing γ-H2A and tubulin (as loading control). Cells were harvested following the strategy given in Figure 6A. Figure 6—figure supplement 1—source data 1.Original files for western blot analysis displayed in Figure 6—figure supplement 1B, F. Original files for western blot analysis displayed in Figure 6—figure supplement 1B, F. Figure 6—figure supplement 1—source data 2.Original files for western blot analysis displayed in Figure 6—figure supplement 1B, F indicating relevant bands. Original files for western blot analysis displayed in Figure 6—figure supplement 1B, F indicating relevant bands. Figure 6—figure supplement 1—source data 3.Source data for Figure 6—figure supplement 1. Source data for Figure 6—figure supplement 1. If Scm3-depleted cells fail to activate the DNA damage checkpoint, we would expect a failure to arrest the cell cycle upon DNA damage, resulting in multibudded cells. However, Scm3-depleted cells arrest at G2/M due to improper kinetochore-microtubule attachment which activates the spindle assembly checkpoint (SAC; Camahort et al., 2007; Stoler et al., 2007). We therefore deleted the SAC component MAD2 in SCM3-AID cells to exclude the effect of a SAC-mediated arrest. These cells were first depleted of Scm3 by treatment with auxin and then, along with mad2D control cells, incubated with or without MMS for 90 min (Figure 6C). While the mad2D cells in the presence of MMS showed few multibudded cells (<5%), the percentage of multibudded cells strongly increased after depletion of Scm3 (>40%), suggesting that Scm3-depleted cells failed to activate the DNA damage checkpoint in the presence of DNA damage. To further validate this result, we monitored the degradation kinetics of Pds1 in the background of MAD2 deletion. mad2∆ SCM3-AID cells were first arrested in G1 by alpha factor and then released in MMS-containing media in the absence or presence of auxin (Figure 6D). Samples were harvested at regular intervals, and Pds1 levels were monitored by western blotting. We could observe lower Pds1 levels and its early removal in the mad2∆ SCM3-AID (+auxin) cells compared to mad2∆ SCM3 (DMSO) cells (Figure 6E and F). This was further verified by an early appearance of anaphase cells (large-budded cells with DAPI in the bud) in the Scm3-depleted cell population (Figure 6G), indicating that these cells are not able to effectively arrest the cell cycle at G2/M in response to DNA damage. Phosphorylation of Scm3 in response to DNA damage The function of Scm3 in DDR could be mediated by a damage-induced post-translational modification of this protein. To examine if Scm3 becomes modified upon DNA damage, we treated SCM3-6HA cells with increasing concentrations of MMS or with 0.02% MMS for increasing duration. We observed slower migrating bands of Scm3 (Scm3*) that became brighter with increasing concentrations of MMS and were present very faintly, even in the untreated cells (Figure 7A, left panel). We observed an increase in the background-subtracted[2]intensity of Scm3* and Scm3*/Scm3 ratio with increasing MMS concentration (Figure 7A, middle, and right panels). A similar observation was made when the cells were treated with 0.02% MMS for increasing time (Figure 7—figure supplement 1A). Since we could also detect Scm3* bands in the untreated cells, its enrichment in response to MMS could be due to a cell cycle arrest caused by MMS. To understand the dynamics of the appearance of Scm3* bands over different cell cycle stages and in response to MMS, we released the bar1∆ SCM3-6HA cells from alpha-factor-mediated G1 arrest into medium in the absence or presence of MMS (Figure 7B). We harvested the cells at indicated time points and evaluated the cell cycle synchrony using bud morphology and DAPI staining (Figure 7C, Figure 7—figure supplement 1B-C). The majority of cells at 0, 30, 60, 90, and 120 min are in G1, S, metaphase, metaphase/anaphase, and anaphase, respectively. We could faintly observe the Scm3* bands after release from the G1 phase in MMS-free (untreated) media, and the band intensity did not change over time. However, when the cells were released in the presence of MMS, we observed an increase in the intensity of the Scm3* bands over time (Figure 7D). These results suggest that the accumulation of Scm3* in the MMS-treated cells is due to DNA damage rather than an effect of the pace of the cell cycle. It is possible that Scm3* bands are phosphorylated forms of Scm3 since the protein has several serine/threonine residues. To test this, we challenged the Scm3-6HA cells with MMS, as in Figure 7A, and resolved the proteins on SDS-PAGE with or without Phos-Tag reagent. The presence of Phos-Tag in the gel enables slow mobility of the phosphorylated proteins and thus further differentiates them from their unphosphorylated forms. The mobility of the Scm3* bands was further reduced with respect to the Scm3 band in Phos-Tag gel compared to the normal gel (Figure 7—figure supplement 1D–E), suggesting that the modification is likely due to phosphorylation. We further verified this by performing a phosphatase experiment. SCM3-6HA cells treated or untreated with MMS were immunoprecipitated and subjected to alkaline phosphatase treatment for 3 hr at 37 °C. The disappearance of the Scm3* band upon phosphatase treatment confirms that the shift was indeed due to phosphorylation (Figure 7—figure supplement 1F). Notably, in several high-throughput studies, Scm3 has been shown to be phosphorylated at the S39, S64, and S165 residues (Lanz et al., 2021; MacGilvray et al., 2020; Zhou et al., 2021). The S64 phosphorylation of Scm3 was found to be enriched in cells after MMS treatment for 2 hr as compared to G1 arrested cells, although the authors could find S64 phosphorylation in only two out of four replicates used in their study (Lanz et al., 2021). However, in the absence of further validation in those studies, our observation of a gradual increase in the Scm3* band intensity with increasing dose of MMS convincingly demonstrates DNA damage-dependent phosphorylation of Scm3. Post-translational modification of Scm3 in response to DNA damage. (A) Left, western blot showing Scm3-6HA and its modified form (Scm3*) along with tubulin as loading control from the cells untreated or treated with indicated concentrations of MMS for 90 min. Middle, intensity of Scm3* with increasing MMS concentrations, normalized to tubulin. Right, the ratio of the modified to unmodified forms of Scm3. Error bars represent the standard error of the mean obtained from two independent experiments. The p-values were determined by a one-way ANOVA test followed by Dunnett’s multiple comparison test. (B) Schematic of the experimental strategy that was followed for detecting Scm3-6HA in G1 arrested cells and following their release from the arrest in the absence or presence of MMS. (C) Representative images showing the cell cycle stages by DAPI staining and bud morphology at indicated time points after release from G1 arrest. (D) Western blot showing Scm3-6HA along with tubulin as a loading control from the cells harvested, as shown in (B). The cell lysates were probed using anti-HA and anti-tubulin antibodies to detect Scm3-6HA and tubulin, respectively. Scale bar = 2 µm. Figure 7—source data 1.Original files for western blot analysis displayed in Figure 7A and D. Original files for western blot analysis displayed in Figure 7A and D. Figure 7—source data 2.Original files for western blot analysis displayed in Figure 7A and D indicating relevant bands. Original files for western blot analysis displayed in Figure 7A and D indicating relevant bands. Figure 7—source data 3.Source data for Figure 7. Source data for Figure 7. Figure 7—figure supplement 1.Phosphorylation of Scm3 in response to DNA damage.(A) Left, western blots showing Scm3-6HA and its modified form (Scm3*) along with tubulin as loading control from SCM3-6HA cells untreated or treated with 0.02% MMS for indicated time points. Middle, the graph showing the intensity of Scm3* with increasing duration of MMS treatment, normalized with respect to tubulin using ImageJ software. Right, the graph represents the ratio of the modified to unmodified forms of Scm3. (B, C) bar1∆ SCM3-HA cells were released from G1 arrest by alpha factor into medium in the absence (B) or presence (C) of MMS. The cell cycle stages of the cells at the indicated time points were determined using DAPI staining and bud morphology and are graphically shown. (D, E) SCM3-6HA cells were treated with the indicated concentration of MMS for 90 min, and total protein was extracted. The proteins were run on 10% SDS-PAGE without (D) or supplemented with 50 µm Phos-Tag reagent (E). The Scm3 band under untreated conditions (black dotted line) gradually shifts upwards with increasing concentration of MMS in the presence of Phos-tag reagent, shown by a basal black line. Two red dotted lines show an increase in the spread of Scm3* in the 0.1% MMS lane as compared to the same shown by two blue lines in the untreated lane. (F) SCM3-6HA cells were treated with MMS or left untreated for 90 min, and total protein was extracted. From the total protein, the immunoprecipitate with anti-HA antibodies was incubated in the presence or absence of alkaline phosphatase (AP) for 3 hr at 37 °C. The proteins were eluted from the beads, and immunoblotting was performed using the same antibodies. (G) Western blots showing Scm3-6HA and its modified form (Scm3*) in the cell lysates from the indicated strains untreated or treated with 0.02% MMS for 90 min. Error bars in (A) represent the standard error of the mean obtained from two independent experiments. The p-values were determined by a one-way ANOVA test followed by Dunnett’s multiple comparison test. Figure 7—figure supplement 1—source data 1.Original files for western blot analysis displayed in Figure 7—figure supplement 1A, D, E, F, G. Figure 7—figure supplement 1—source data 2.Original files for western blot analysis displayed in Figure 7—figure supplement 1A, D, E, F, G indicating relevant bands. Figure 7—figure supplement 1—source data 3.Source data for Figure 7—figure supplement 1. Phosphorylation of Scm3 in response to DNA damage. (A) Left, western blots showing Scm3-6HA and its modified form (Scm3*) along with tubulin as loading control from SCM3-6HA cells untreated or treated with 0.02% MMS for indicated time points. Middle, the graph showing the intensity of Scm3* with increasing duration of MMS treatment, normalized with respect to tubulin using ImageJ software. Right, the graph represents the ratio of the modified to unmodified forms of Scm3. (B, C) bar1∆ SCM3-HA cells were released from G1 arrest by alpha factor into medium in the absence (B) or presence (C) of MMS. The cell cycle stages of the cells at the indicated time points were determined using DAPI staining and bud morphology and are graphically shown. (D, E) SCM3-6HA cells were treated with the indicated concentration of MMS for 90 min, and total protein was extracted. The proteins were run on 10% SDS-PAGE without (D) or supplemented with 50 µm Phos-Tag reagent (E). The Scm3 band under untreated conditions (black dotted line) gradually shifts upwards with increasing concentration of MMS in the presence of Phos-tag reagent, shown by a basal black line. Two red dotted lines show an increase in the spread of Scm3* in the 0.1% MMS lane as compared to the same shown by two blue lines in the untreated lane. (F) SCM3-6HA cells were treated with MMS or left untreated for 90 min, and total protein was extracted. From the total protein, the immunoprecipitate with anti-HA antibodies was incubated in the presence or absence of alkaline phosphatase (AP) for 3 hr at 37 °C. The proteins were eluted from the beads, and immunoblotting was performed using the same antibodies. (G) Western blots showing Scm3-6HA and its modified form (Scm3*) in the cell lysates from the indicated strains untreated or treated with 0.02% MMS for 90 min. Error bars in (A) represent the standard error of the mean obtained from two independent experiments. The p-values were determined by a one-way ANOVA test followed by Dunnett’s multiple comparison test. Figure 7—figure supplement 1—source data 1.Original files for western blot analysis displayed in Figure 7—figure supplement 1A, D, E, F, G. Original files for western blot analysis displayed in Figure 7—figure supplement 1A, D, E, F, G. Figure 7—figure supplement 1—source data 2.Original files for western blot analysis displayed in Figure 7—figure supplement 1A, D, E, F, G indicating relevant bands. Original files for western blot analysis displayed in Figure 7—figure supplement 1A, D, E, F, G indicating relevant bands. Figure 7—figure supplement 1—source data 3.Source data for Figure 7—figure supplement 1. Source data for Figure 7—figure supplement 1. Since Mec1 and Tel1 kinases are the sensor kinases that contribute to the activation of the DDR pathway through protein phosphorylation, we tested if Scm3 undergoes a Mec1- and/or Tel1-dependent phosphorylation in response to MMS. We tested the phosphorylation status of Scm3-6HA in the single (sml1∆ mec1∆, sml1∆ tel1∆) and also in the double (sml1∆ mec1∆ tel1∆) kinase mutants in the presence of MMS. We could not observe any loss of Scm3 phosphorylation in either of the mutants (Figure 7—figure supplement 1G), suggesting at least the sensor kinases Mec1 or Tel1 are not responsible for Scm3 phosphorylation. Discussion The bona fide function of Scm3 is to deposit Cse4 at the centromeres during S phase in budding yeast to facilitate kinetochore formation. The observation that Scm3 persists not only at the centromeres throughout the cell cycle but also associates with the bulk of the chromatin argues for additional kinetochore-independent functions of Scm3 in maintaining genome stability. In metazoans, the Scm3 homolog HJURP was initially identified as a protein involved in DDR, and its role in CENP-A deposition was only discovered later. How HJURP regulates the DDR pathway is not well understood. The DDR role of Scm3 has not previously been reported in budding yeast to our knowledge. Showing that Scm3 also contributes to the DDR pathway in budding yeast is important since this organism is distinct from metazoans in terms of harboring small 125 bp point centromeres, contrasting the megabase pair large regional centromeres in metazoans, and its centromeres are not epigenetically determined. Here, for the first time, we report that Scm3, perhaps upon phosphorylation, promotes DNA damage repair by contributing to the activation of the DNA damage checkpoint, and in the process, it possibly associates with DDR proteins at the DNA damage sites (Figure 8). Our findings significantly advance knowledge of how CENP-A chaperones can be involved in the DDR pathway. A working model summarizing the role of Scm3 in the DNA damage response (DDR). Left, in wild-type cells, a subset of Scm3 present in the nucleus (green) is phosphorylated upon DNA damage. The phosphorylated Scm3 (p-Scm3) associates with DSB sites, colocalizes with γ-H2A, and spreads to chromatin flanking the DSB site. Possibly, p-Scm3 facilitates proper activation of Rad53 through its phosphorylation, leading to cell cycle arrest. Additionally, p-Scm3 co-localizes with Rad52 and assists in DSB repair. Right, in Scm3-depleted cells, there is an increase in endogenous DNA damage, corresponding to more Rad52 foci, likely due to the inability to repair DSBs, and cell viability drops. In parallel, reduced Rad53 activation causes improper DDR-mediated cell cycle arrest, generating multibudded cells and possibly aneuploid cells, leading to cell death. Phenotypes associated with the loss of Scm3 are shown in red. Graphical elements in the figure are partially adapted from the Servier Medical Art Repository (https://smart.servier.com), licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Lack of Scm3 increases DNA damage sensitivity It is technically challenging to perform a growth-based sensitivity assay using cells depleted for an essential gene. To circumvent this issue with Scm3, which is essential for cell survival, we partially depleted Scm3 and found that these cells were sensitive to genotoxic agents, including MMS, HU, and CPT (Figure 1, Figure 1—figure supplement 2A). The observed sensitivity is not due to problems in kinetochore formation or cell cycle progression in the absence of Scm3, as other kinetochore mutants or a metaphase block in wild-type cells did not show similar sensitivity (Figure 1—figure supplement 3). The arguments favoring the possible centromere-independent DDR functions of Scm3 can be gleaned as follows. From comparing the domain organization of Scm3 with HJURP (Figure 1—figure supplement 1A), we noticed that, besides the CENP-A/Cse4 binding domain, both HJURP and Scm3 have a common DNA binding domain, which is dispensable for CENP-A/Cse4 binding and also dispensable for Mis18 or Ndc10 binding in metazoans or budding yeast, respectively. Both in vitro and in vivo evidence demonstrate binding of the DNA binding domain to DNA (Kato et al., 2007; Mizuguchi et al., 2007), suggesting this domain can recruit Scm3 to non-centromeric DNA damage sites. In support of this, Scm3 has recently been shown to be phosphorylated in an MMS-dependent manner at S64 (Lanz et al., 2021), which, interestingly, lies within the DNA binding domain. Among other non-essential regions of Scm3, neither the NLS region nor the C-terminal region is involved in DDR (Figure 1—figure supplement 1B). On the other hand, the D/E-rich region, which is important for Scm3 stability (Stoler et al., 2007), forms a disordered domain as per alpha-fold prediction and hence is believed to be capable of interacting with multiple proteins or can act as a scaffold for engaging several protein-protein interactions which are required in DDR. It will be interesting to test whether and how CENP-A might influence the DDR function of Scm3. Analysis of damage-induced localization of CENP-A and isolation of separation-of-function (centromeric vs non-centromeric) mutants of Scm3 could provide insights into the role of CENP-A in Scm3’s DDR function. MMS halts replication forks due to the formation of DNA adducts, which eventually generate recombinogenic lesions (Conde and San-Segundo, 2008). In yeast, these lesions are repaired primarily through homologous recombination (HR), facilitated by the Rad52 epistasis group of proteins (Pizzul et al., 2022; Sirbu and Cortez, 2013). In the presence of DNA damage, Rad52 relocalizes to form bright foci, which mark the repair centers. Strikingly, we observed that the number of Rad52 foci is increased in the absence of Scm3, even without external DNA damage (Figure 2C, Left), with maximal accumulation noticed at 60 min post-G1 release, which coincides with the timing of DNA replication (Figure 2—figure supplement 2C). This indicates that Scm3 might be required to avoid generating DNA lesions during replication, which itself is genotoxic. In support of this, it was previously observed that cells arrest during S phase in the absence of Scm3 (Camahort et al., 2007). In yeast, although HR is the preferred repair pathway, an alternative pathway named non-homologous end joining (NHEJ) exists. The absence of epistatic interaction between SCM3 and RAD52 (Figure 1C) suggests that Scm3 may function in ways other than the Rad52-mediated classical HR pathway. In this context, it would be interesting to test how Scm3 might interact with the key proteins of the NHEJ pathway, such as Ku70/Ku80 and Lig4 (Gao et al., 2016). It is possible that Scm3 may promote a specific chromatin architecture facilitating that DSB ends stay together and are accessible for NHEJ-mediated end joining. Association of Scm3 with non-centromeric loci In budding yeast, chromosome XII harbors ribosomal DNA (rDNA) with around 150 repetitive loci (Dammann et al., 1993; Smith, 2022). Recombination among these repeats excises rDNA circles, and therefore, efficient DNA damage repair through HR at these loci is crucial for preserving genomic stability. Notably, mammalian HJURP binds to the rDNA region and maintains its stability (Kato et al., 2007). The knockdown of HJURP using siRNA resulted in increased rDNA recombination events and chromosome instability (Kato et al., 2007). The presence of Scm3 at the rDNA loops (Figure 3A and F) suggests that Scm3, like HJURP, might also be important in regulating the recombination and repair processes at these rDNA loci. During DSB repair, lesions generated at multiple sites are recruited to repair centers, which are marked by Rad51 and Rad52 (Lee et al., 2003; Lisby et al., 2001; Miyazaki et al., 2004). The observed statistically significant co-localization of Rad52 and γ-H2A with Scm3 in response to DNA damage (Figure 4A) implicates the recruitment of Scm3 at multiple DNA damage sites distributed over several repair centers. Normally, these proteins localize independently onto chromatin owing to their specific functions and show limited overlap (Figure 4—figure supplement 1), but in response to DNA damage, they significantly co-localize with each other aiding in the process of damage repair. This was supported by an overall increase in the association of Scm3 with the non-centromeric chromatin sites, the majority of which, through in-silico analysis, appear to be DNA-damage-prone sites (Figure 3—figure supplement 1). At the damage sites, it is possible that Scm3 might physically interact with Rad51/Rad52 and/or MRX (Mre11, Rad50, Xrs2) complex through its HR or DNA binding or the D/E rich domain (Figure 1—figure supplement 1). However, we failed to observe any interaction of Scm3 at least with Rad52 using a co-immunoprecipitation. Although DNA damage sites are marked by γ-H2A in budding yeast, γ-H2A is also observed at stalled replication forks, fragile sites, telomeric, and heterochromatin regions (Kirkland et al., 2015; Kitada et al., 2011; Bewersdorf et al., 2006). Therefore, the increased co-localization between Scm3 and γ-H2A upon MMS treatment (Figure 4D–F) suggests that Scm3 may be recruited to those sites as well. The presence of Scm3 up to 3 kb distal from the cut site (Figure 5C) is consistent with the pattern for γ-H2A, which also spreads distal to the cut site (Lee et al., 2014). Though Scm3’s presence at the cut site peaked at 2 hr following HO induction, it persisted at the cut site even when ~60% of the cut DNA was repaired, indicating that Scm3 remains associated with damage sites during the repair process. Importantly, in the absence of Scm3, the repair of the cut site was drastically reduced, suggesting that the localization of Scm3 at the cut site is required for the repair of the damage. These findings suggest that the localization of Scm3 at the DSB sites and its spreading up to –3 kb promote the repair process. Although how Scm3 might promote repair is currently not understood, it may facilitate multiple steps in the repair process, which will be investigated in future studies. Scm3 regulates the DNA damage checkpoint We wanted to address the mechanism by which Scm3 might be involved in DDR. Inefficient Rad53 phosphorylation (Figure 6B) and abrogation of the cell cycle arrest (Figure 6E and C) in the presence of DNA damage in Scm3-depleted cells suggest that these cells are defective in DDR checkpoint activation. Since Rad53 is known to be phosphorylated in a Mec1-dependent manner (Gilbert et al., 2001; Pellicioli and Foiani, 2005), we examined but failed to observe any attenuation of Mec1 activity in Scm3-depleted cells in the presence of DNA damage (Figure 6—figure supplement 1F). Therefore, we are uncertain about the cause of improper Rad53 phosphorylation; a defect in its auto-activation or in the activity of other mediator kinases, for example Tel1, may be responsible. Nevertheless, given the increased phosphorylation of Scm3 in response to DNA damage, phosphorylated Scm3 may be required to activate Rad53 (Figure 7A). Although we found that Scm3 phosphorylation is Mec1 independent (Figure 7—figure supplement 1G), other kinases may be involved. While the involvement of CDKs in the DNA damage checkpoint is not well understood, it is known that CDKs contribute to the phosphorylation of both Rad52 and Rad51 to promote repair (Lim et al., 2020). Given that the centromeric association of Scm3 varies with the cell cycle stage (Mishra et al., 2011), probably due to oscillating levels of CDK activity, the DNA damage-dependent phosphorylation of Scm3 might also be regulated by CDKs. However, this does not rule out the involvement of other kinases, including Rad53 and Tel1, which are closely associated with the DNA damage checkpoint pathway. Further investigation is required to determine the kinases involved in the Scm3 phosphorylation. In summary, we report here that, like HJURP, Scm3 in budding yeast also possesses functions in DDR, indicating that the centromere-independent functions of the CENP-A chaperone are evolutionarily conserved. Although the chromatin landscape of budding yeast is far more ‘open’ with lesser involvement of epigenetic determinants than in metazoans, the inherent similarity in the DNA damage repair pathway may necessitate the utilization of these chaperones in a similar fashion in both cell types. Not much is known about how HJURP is involved in the DDR pathway. As we find that Scm3 is involved in the proper activation of the DNA damage checkpoint (Figure 8), this could be tested for HJURP in metazoans. Abrogation of this surveillance function may lead to aneuploidy and disease states. Our findings on Scm3 will pave the way for future work using yeast as a model to decipher genome-wide functions of the CENP-A chaperone, like HJURP, which is crucial given its genome-wide localization and evidence of its modulation in several patients. Materials and methods Yeast strains All Saccharomyces cerevisiae strains used in this study are derived from W303 genetic background and are mentioned in Supplementary file 1A. C-terminal tagging (AID, HA, Myc, GFP) or gene deletions were performed using PCR-based integration at endogenous locations as described before (Janke et al., 2004; Longtine et al., 1998; Wach, 1996). Standard lithium acetate-based yeast transformation methods were employed for all genetic manipulations (Daniel Gietz and Woods, 2002). Media, reagents, and growth conditions Yeast strains were grown using yeast extract, peptone, and dextrose (YPD; 1% wt/vol yeast extract, 2% wt/vol peptone, 2% wt/vol dextrose for liquid and an additional 2% % wt/vol agar for plates) at 30 °C (Sherman, 2002). For plates containing MMS, HU, and CPT (Sigma Chemicals, Switzerland), the drugs were added to YPD plates at appropriate concentrations. To arrest the cells at the G1 or metaphase stage of the cell cycle, alpha factor (T6901, Sigma Chemicals, Switzerland) or nocodazole (M1404, Sigma Chemicals, Switzerland) was added to the cells at the indicated concentrations. For HO endonuclease induction, strains were grown in 1% yeast extract, 2% peptone, containing 3% glycerol before adding 3% galactose. For western blotting, immunoprecipitation, or immunofluorescence studies, the primary antibodies used were rat anti-HA (3F10, Roche), mouse anti-HA (12CA5, Roche), mouse anti-Myc (9E10, Roche), rat anti-tubulin (MCA78G, Serotec), rabbit anti-Rad53 (ab104232, Abcam), rabbit anti-Rad51 (PA5-34905, Invitrogen), and rabbit anti-Histone H2A (phospho-S129; ab15083, Abcam). The secondary antibodies used were Rhodamine (TRITC)-conjugated goat anti-Rat (1:200, Jackson), Alexa Fluor 488-conjugated goat anti-Mouse IgG (1:200, Jackson), Rhodamine (TRITC)-conjugated goat anti-Rabbit (1:200, Jackson), HRP-conjugated goat anti-mouse IgG (1:200, Jackson), HRP-conjugated goat anti-rat (1:200, Jackson), HRP-conjugated goat anti-rabbit (1:200, Jackson). Cell spotting and viability assay The cells were grown in yeast extract, peptone, and dextrose (YPD) at 30 °C conditions till the mid-log phase. The cultures were then 10-fold serially diluted and spotted on the plates containing auxin (dissolved in DMSO) or other DNA-damaging agents. All the reagents were added to YPD or specific dropout plates. After spotting, the plates were incubated at 30 °C for 2–3 days before they were photographed, depending on the growth rate. For treatment of cells in liquid culture, mid-log grown cells were treated with auxin (dissolved in DMSO) or MMS for the indicated periods before they were harvested and spotted on YPD plates or plates containing DNA damaging agents. To measure cell viability, an equal number of cells were plated on drug-free or drug-containing YPD plates. The cells were grown at 30 °C for 2 days, and the number of colonies was counted. The colonies formed on the drug-free plate were taken as 100% viability. G1 arrest and release Cells were arrested in G1 phase by adding 0.5 μg/ml α-factor to early log phase cells in liquid culture (Amon, 2002). The cells were incubated for 2–3 hr or until at least more than 90% of cells showed shmoo morphology. For the release of the cells from α-factor arrest, the cells were harvested and washed twice with pre-warmed water at 30 °C which was followed by washing twice with pre-warmed α-factor-free media at 30 °C with at least 10 times the volume of the initial culture. The cells were then released in α-factor-free media, and samples were collected at different time points. Fluorescence imaging For live cell imaging, the samples were harvested at indicated time points and washed twice in 0.1 M phosphate buffer before imaging. The cells were processed for DAPI staining, as mentioned elsewhere (Mittal et al., 2020; Shah et al., 2023). Typically, the cells were fixed with 4% formaldehyde at RT for 5 min. The fixed cells were washed twice with 0.1 M phosphate buffer (pH 7.5), vortexed in freshly prepared 50% ethanol for 30 s, and rewashed with 0.1 M phosphate buffer. Before imaging, the cells were resuspended in freshly prepared DAPI (1 μg/ml, Invitrogen) solution in phosphate buffer for 20 min. The images were acquired with a Zeiss Axio Observer Z1 fluorescence microscope (63×or 100×[3]1.4 NA) in z-stack mode (0.2–0.5 μm spacing). Chromatin spreads Chromatin spreads were performed, as described previously (Ma et al., 2023; Mehta et al., 2014; Shah et al., 2023). Briefly, mid-log (O.D.600 = ~1.0) grown cells were harvested and washed once with spheroplasting buffer (1.2 M sorbitol in 0.1 M phosphate buffer). The cells were resuspended in 0.5 ml of the same buffer supplemented with 5 µl of β-mercaptoethanol and 12.5 µl of zymolyase 20T (10 mg/ml, MP Biomedicals, USA) and incubated at 30 °C for 1 h. Once 80–90% of the cells were spheroplasted (by observing under the microscope), the spheroplasting was stopped by adding 1 ml of ice-cold stop solution (0.1 M MES- pH 6.4, 1 mM EDTA, 0.5 mM MgCl2, 1 M Sorbitol). The spheroplasts were centrifuged at 2000 rpm for 2 min and resuspended in 120 µl of ice-cold stop solution. About 60 µl of spheroplasts were mounted on an acid-washed clean glass slide. The cells were treated with freshly made paraformaldehyde solution (4% paraformaldehyde, 3.4% sucrose), followed by 1% Lipsol (LIP Equipment and Services) solution for cell lysis. The lysed cells were homogenously spread over the slide and air-dried at RT. After overnight drying, the slides were treated with 0.4% Kodak Photoflow-200 to avoid photobleaching, followed by 5% skim milk as a blocking solution, which was covered with coverslips. The coverslips were removed, and the slides were incubated with primary and secondary antibodies (1:200) for 60 min with three times PBS washing between antibody treatments. The slides were then incubated with 100 µl of DAPI (1 µg/ml, Invitrogen) for 30 min. After PBS wash for 5 min, 100 µl of mounting solution (90% glycerol supplemented with 1 mg/ml p-phenylenediamine) was added onto the slides. A clean coverslip was placed over a slide and was sealed with transparent nail paint. Microscopic image analysis Images were processed using Zeiss Zen 3.1 software. The z-stacks with the best signal for a particular channel were extracted and merged with the best stack for the other channel. For intensity calculation, a region of interest (ROI) was drawn around the Scm3/Ndc10/γ-H2A+DAPI signal, and the intensity of Scm3/Ndc10/γ-H2A was measured from each chromatin mass or spread (DAPI). An ROI of the same size was put elsewhere in the background area, from where intensities were calculated. The average of the background intensities was then subtracted from the Scm3/Ndc10/γ-H2A intensity obtained from the same spread to get the background-subtracted intensity depicting each dot in the box plot of the respective figures as mentioned previously (Mittal et al., 2020; Shah et al., 2023). For Pearson’s correlation coefficient (PCC) values, the merged z-stacks and the ‘Coloc’ tool from the ‘Imaris 8.0.2’ software were used. The ‘automatic thresholding option’ in the ‘Coloc’ tool was used to calculate the threshold for each fluorescence emission channel. The PCC values were recorded separately for each individual spread. The colocalization was described as no (PCC <0.1), partial (PCC = 0.3–0.5) and complete (PCC >0.5; Ma et al., 2023; Prajapati et al., 2018; Zinchuk and Grossenbacher-Zinchuk, 2014). Induction of a site-specific DSB NA14 (Fangaria et al., 2022) cells were grown till 0.3 OD in the presence of 3% glycerol. 5 OD of the cells were harvested (0 hr), and the remaining cells were treated with 3% galactose for 4 hr. 5 OD cells were harvested every hour till 4 hr. The cells were lysed using glass beads in lysis buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris pH 8, and 1 mM EDTA pH 8.0), total DNA was isolated as described before (Hoffman, 1997) and was solvent extracted using phenol-chloroform-isoamyl alcohol (PCI). The genomic DNA was precipitated and finally resuspended in 30 µl 1 X TE. The concentration of DNA was measured using a nano spectrophotometer. About 30 ng of DNA was used for PCR to detect the DNA break using primers OSB289 and kanB1 (Fangaria et al., 2022). Primers against TUB2 ORF were used as a control. ChIP assay and qPCR quantification ChIP assay was performed as described previously (Fangaria et al., 2022; Kumar et al., 2021; Makrantoni et al., 2019; Mehta et al., 2014). First, cells were grown in the presence of 3% glycerol till 0.3 OD. 60 OD cells were harvested (0 hr), and the remaining cells were treated with 3% galactose. 60 OD of cells were harvested every hr till 4 hr. The cells were then fixed with 1% formaldehyde for 30 min at 25 °C at 100 rpm, followed by quenching by adding glycine to a final concentration of 125 mM. The cells were then harvested and washed twice in ice-cold TBS buffer (20 mM Tris–HCl pH 7.5, 150 mM NaCl) and once with 10 ml of FA lysis buffer (50 mM Hepes–KOH pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate) supplemented with 0.1% SDS. The pellet was resuspended in 500 µl of 1 X FA lysis buffer supplemented with 0.5% SDS, 1 mM PMSF, 1 X protease inhibitor cocktail (PIC). The cells were lysed using 0.5-mm glass beads using a mini-bead beater (BIOSPEC, India) for seven cycles (1 min ON, 2 min OFF on ice). The lysate was collected in a pre-chilled 1.5 ml Eppendorf tube and centrifuged twice at 16,000 x g for 15 min at 4 °C. The pellet was resuspended in 300 µl ice-cold 1 X FA lysis buffer supplemented with 0.1% SDS, 1 mM PMSF, and 1 X PIC. The chromatin was sheared to 200–600 bps using a water bath sonicator (Diagenode SA, Picoruptor, BC 100, 27 LAUDA Germany) for 30 cycles of 30 s ON / 30 s OFF at 4 °C. After clarification of the lysate by centrifugation at 16,000 x g for 10 min at 4 °C, 3–5 µg of appropriate antibodies were added and incubated at 4 °C overnight with gentle rotation. Subsequently, 50 µl Protein-A conjugated Sepharose beads (17-0780-1, GE Healthcare) were added and incubated for 2 hr at 4 °C with rotation. The beads were washed twice with IP wash buffer I (1 X FA lysis buffer, 0.1% SDS, 275 mM NaCl), followed by one wash in IP wash buffer II (1 X FA lysis buffer, 0.1% SDS, 500 mM NaCl, III 10 mM Tris pH 8.0, 250 mM LiCl, 0.5% NP-40, 0.5% sodium deoxycholate, 1 mM EDTA), and 1 X TE at room temperature. The beads were resuspended in elution buffer, and the chromatin was eluted by boiling at 65 °C. The eluate was then decrosslinked overnight at 65 °C, followed by Proteinase K (SRL, India) treatment for 2 hr at 45 °C. The DNA was purified by PCI-based purification and precipitated overnight in chilled ethanol at –80 °C. The enrichment of obtained chromatin fragments was estimated using qPCR (Bio-Rad CFX96, USA) using specific primers targeting specific and non-specific (negative control) chromatin loci, listed in Supplementary file 1B. As described before (Kumar et al., 2021; Shah et al., 2023), the following equation was used to estimate the percentage of chromatin enrichment. ChIP efficiency = Enrichment/Input X 100; Enrichment/Input = E˄-ΔCT; ΔCT = CT(ChIP) − [CT(Input) − LogEX(D)]; E=primer efficiency value, CT = Threshold values obtained from qPCR, D=Input dilution factor. E was estimated as {[10^(–1/slope)]– 1} from standardization graphs of CT values against dilutions of the input DNA. Chromatin immunoprecipitation (ChIP) and sequencing ChIP assay was performed as described above with modifications. The cells were grown till mid-log phase and treated with nocodazole (20 μg/ml) for 90 min to arrest cells at metaphase. Cells were subsequently treated with 0.05% MMS for an additional 90 min. The cells were harvested and processed for immunoprecipitation, as mentioned above, except Protein-A conjugated dyna beads (Invitrogen, 10003D) were used instead of sepharose beads. 10 ng of DNA eluate was taken to prepare the NGS library using a TruSeq ChIP sample preparation kit from Illumina. The library was prepared as per the manufacturer’s protocol. Library QC was performed by measuring the concentration and size of the libraries by using the 4150 Tapestation system from Agilent and Qubit dsDNA HS assay kit (Thermo Fisher Scientific). The libraries were sequenced using the Illumina platform in paired-end mode with a read length of 151 bp by Macrogen Asia Pacific Pte. Ltd, Singapore. Bioinformatics analysis The ChIP-Seq analysis was performed by Genotypic (Bengaluru, India). The raw reads were processed using FastQC (Andrews, 2010) for quality assessment and pre-processing, which includes removing the adapter sequences and low-quality bases ( 300 cells. (7) Please revise the title and incorporate "budding yeast" or "Scm3" into the title. (8) Please try to shorten the discussion and avoid re-iterating results already covered in the Results section. (9) Please be careful not to overstate the results. As one example: page 14 "Scm3… associates with the DDR proteins at the DNA damage sites." A direct protein-protein interaction has not been demonstrated. So please rephrase. (10) In the abstract, line 24, "interacts with…" should be "genetically interacts with…". (11) Line 203: Please rephrase "also referred to as the NLS". NLS is not a synonym for a bromodomain. Therefore, "..which also harbor an NLS" or "… which also harbor a candidate NLS" would be more appropriate. (12) Please have the manuscript proofread for English grammar and spelling, in particular the introduction. [Editors' note: further revisions were suggested prior to acceptance, as described below.] Thank you for resubmitting the paper entitled "Evidence of centromeric histone 3 chaperone involved in DNA damage repair pathway in budding yeast" for further consideration by eLife. Your revised article has been evaluated by a Reviewing Editor and two of the original reviewers. Two major remaining concerns were not sufficiently addressed by the revision: (1) The claim that the DDR checkpoint is impaired in Scm3-depleted cells is not substantiated. The new immunoblot in Figure 6A (formerly 6D) still shows no obvious reduction of Rad53 phosphorylation in Scm3-depleted cells. Similarly, the new immunoblot for Pds1 in Figure 6E does not give any strong indication that Pds1 degrades earlier in Scm3-depleted cells. (Compare, for example: https://pmc.ncbi.nlm.nih.gov/articles/PMC312708/figure/F5/). (2) The ChIP-seq experiment remains largely inconclusive regarding whether there is increased binding of Scm3 to chromatin after MMS treatment and whether there is enrichment at fragile sites. The ChIP profiles from untreated and MMS-treated cells look highly similar, and it remains unclear whether differences in peak height between control and MMS are inter-experiment variability or MMS-induced changes. While a few Scm3 peaks overlap with fragile sites based on the new data you report, this is the case both in untreated and in MMS-treated cells. There is no clear increase after MMS treatment and in fact, some sites lose Scm3 enrichment after MMS treatment. 1. General Statements We sincerely thank all three reviewers for their professional and constructive feedback. We appreciate the thorough evaluation of our manuscript and are committed to revising both the manuscript and supplemental materials based on the suggestions. We have carefully considered each comment and have addressed most of them in the initial revised version, which has been transferred. Additionally, we are currently conducting new experiments to provide the requested data to address a few comments. We are confident that these revision experiments will be completed in a couple of months or so, which will significantly enhance the quality of our study. 2. Description of the planned revisions Reviewer #1 (Evidence, reproducibility and clarity): In the manuscript by Agarwal and Ghosh, the authors examine yeast Scm3 function in the DNA damage response. They show that Scm3 loss results in DNA damage sensitivity and more Rad52 foci. Importantly, Scm3 is recruited to DSB sites using an HO-cut site and its loss results in an attenuated DNA damage checkpoint as measured by Rad53 phosphorylation. The authors demonstrate convincingly that Scm3, like its human counterpart HJURP, plays a role in the DNA damage response through altered Rad53 activation. However, what its specific role in DNA repair is remains ambiguous. Major comments: A. The phosphorylation aspect of Scm3 is intriguing and the authors show that Mec1 is not responsible for mediating its phosphorylation. Tel1 is another kinase that should be examined. We thank the reviewer for the suggestion. We are in the process of examining the role of Tel1 kinase on Scm3 phosphorylation. The results from the experiment will be incorporated in the manuscript. All other major and minor comments of Reviewer #1 have been addressed. Please see the section 3 below. Reviewer #2 (Evidence, reproducibility and clarity): This manuscript describes a study implicating the Scm3 protein from budding yeast in the DNA damage response (DDR). Scm3 is a chaperone protein, whose main role is considered to be the loading of CENP-A(Cse4) at centromeres to facilitate chromosome segregation. However, the human ortholog of Scm3, HJURP, is known to have a role in DDR and in this study the authors provide evidence that Scm3 is also involved in the DDR in yeast. For the most part, the results presented support the conclusions made. All the major and minor comments of Reviewer #2 have been addressed. Please see the section 3 below. The western blots in the paper are not always entirely convincing. In addition, they are not described in enough detail to understand if a membrane was cut or if multiple gels were run. For example, the tubulin loading in Figure 6D is interrupted toward the end of the blot and the bands in Figure 7D go in different directions for the two blots for the MMS treated cells. In figure 6B, there are no detectable phospho-forms of Rad53 detected on the upper blot for the WT and scm3 lanes even though quantification is given on the right. It would be good to present better examples of the westerns or at least better describe what the reader is visualizing so the quantification and conclusions can be understood. How were the blots quantified? How were the westerns run and processed? We have now included a separate paragraph in Materials and methods regarding the gel run, processing and quantification of the western blots in the revised manuscript for better understanding of the readers: “To detect Scm3-6HA, Rad53, and g-H2A, the total proteins isolated from the appropriate cells were run on 12%, 8%, and 15% SDS gels, respectively. The proteins were transferred to the membranes, which were cut to detect the above proteins and the control protein tubulin separately. For the quantification of the bands on the western blots, a region of interest (ROI) was made around the band of interest, and the intensity of the band was calculated using ImageJ. A same ROI from a no-band area of the blot was used to calculate the background intensity. The background intensity was subtracted from the band intensity. The same process was done for the tubulin bands. The intensity of the target bands (Scm3-6HA, Rad53, and g-H2A) was divided by control tubulin band intensity to get the normalized values for the target bands, which were plotted using GraphPad Prism 9.0 (Version 9.4.1) software.” This has been added in page 25, lines: 881-890.” Furthermore, we will again perform the experiments for a better representation of the western blots in figures 6B, D, and 7D. The argument that scm3 depletion leads to a defect in DNA damage checkpoint activation is not strongly supported. Monitoring exit from the cell cycle by multibudding is not the most rigorous assay, especially since the image shows one cell with 5 nuclei. The authors should release cells from G1 into auxin and MMS and monitor cell cycle progression at least one other cell cycle marker, such as anaphase onset, DNA replication and/or Pds1 levels. As per the reviewer’s suggestion, in order to support our argument that the absence of Scm3 causes a defect in DNA damage checkpoint activation, we will examine if these cells abrogate G2/M arrest and show an early anaphase onset. For this, we will monitor the levels of Pds1, as a marker of anaphase onset, along the cell cycle in wild type and Scm3-depleted cells both deleted for Mad2 to remove any inadvertent effect of spindle assembly checkpoint. The schematics of the experimental workflow is given in Author response image 1. Typically, the cells will be released from α factor arrest in the absence or presence of auxin (for the depletion of Scm3) and in the absence or presence of MMS. The samples will be harvested at the indicated time points and will be analyzed for: Western blot: Pds1-Myc (to detect anaphase onset) Western blot: Pds1-Myc (to detect anaphase onset) Western blot: Rad53 and p-Rad53 (to detect DNA damage activation) (iii) Immunofluorescence: Tubulin (to detect cell cycle stages) Western blot: Rad53 and p-Rad53 (to detect DNA damage activation) (iii) Immunofluorescence: Tubulin (to detect cell cycle stages) The results of the above experiment will be incorporated in the revised manuscript. The schematic of the experimental strategy to be followed to elucidate the role of Scm3 in DNA damage checkpoint activation. Minor comments: A. The ChIP-seq data is not publicly accessible. There is no reference to the data being available to review. The data will be uploaded to the public domain. All other major and minor comments of Reviewer #3 have been addressed. Please see the section 3 below. 3. Description of the revisions that have already been incorporated in the transferred manuscript Reviewer #1: Major comments: A. It is unusual to see multiple DNA repair foci as those observed in Figure 2B. What is the distribution of cells with 1, 2, 3, 4, or more foci? Are more observed in SCM3-AID cells perhaps suggesting that the DSB ends are not being clustered as would be expected in WT cells exposed to DNA damage? As per the reviewer’s comment, we have included a graph (Author response image 2) showing the distribution of cells with 1, 2, 3, 4, or more Rad52-GFP foci when they are treated with MMS. There are more cells with 4 or more foci when Scm3 is depleted (SCM3-AID + Auxin) compared to the wild type (SCM3-AID). The average number of Rad52-GFP foci per cell presented in Author response image 2B (2.8 in the mutant vs. 1.9 in the wild type) is well in accord with the previous report (Conde and San-Segundo, 2008), where the same was reported as ~2.5 in the cells lacking a methyl transferase Dot1, vs ~ 1.5 in the wild type. More Rad52-GFP foci in MMS-treated cells lacking Scm3 may arise due to the creation of too many damaged sites to be accommodated in 1-2 foci and/or due to the inability of the cells to cluster the DSB ends. The percentage of wild type (SCM3-AID) and Scm3 depleted (SCM3-AID+Auxin) cells harboring indicated numbers of Rad52-GFP foci upon treatment with 0. 02% MMS. This result has been incorporated as a new supplementary Figure S4C and new text has been added in the revised manuscript as: “We further quantified the distribution of cells with 1, 2, 3, or >4 Rad52-GFP foci in wild type (SCM3-AID) or Scm3 depleted (SCM3-AID + auxin) cells treated with MMS. Scm3 depleted cells showed a significantly higher number of cells with more than >4 Rad52-GFP foci, suggesting the possibility of the creation of too many damaged sites to be accommodated in 1-2 foci or the inability of such cells to cluster the DSB ends.” in page 7, lines: 237-241. B. The peaks with increased Scm3 recruitment by ChIP-seq upon MMS is confusing as MMS does not induce specific damage at genomic locations. Is Scm3 being recruited at other genomic sites that might be more susceptible to DNA damage? Is Scm3 recruited to Pol2 sites for example? Or fragile sites? We believe that the MMS induced increase in association of Scm3 with the noncentromeric chromatin loci depends on MMS sensitive vulnerable chromosomal sites. We agree with the reviewer that MMS might cause DNA damage at these sites, leading to Scm3 occupancy at those sites. Therefore, we compared the sites of Scm3 occupancy with possible such sites available from the literature that include fragile sites, RNA Pol II binding sites, double strand break hotspots, and coldspots. Based on our analysis, we have included the following lines in the ‘discussion’ section in page 16-17, lines 566-594 as follows: “Moreover, an overall increase in the chromatin association of Scm3 in response to MMS also suggests that Scm3 might be recruited to several repair centers or sites that are susceptible to DNA damage, for example, the fragile sites (Figure 3B, C, E, S6). These sites in yeast are DNA regions prone to breakage under replication stress, often corresponding to replication-slow zones (RSZs) (Lemoine et al., 2005). These regions include replication termination (TER) sequences, tRNA genes, long-terminal repeats (LTRs), highly transcribed genes, inverted repeats/palindromes, centromeres, autonomously replicating sequences (ARS), telomeres, and rDNA (Song et al., 2014). Since the helicase Rrm3 is often associated with these fragile regions (Song et al., 2014), we compared Scm3 binding sites with the top 25 Rrm3 binding sites from the literature (Azvolinsky et al., 2009). In untreated cells, Scm3 sites overlapped with three Rrm3 sites on chromosomes X, XII, and XIV. Whereas in MMS treated cells, overlapping was found with four Rrm3 sites, with two (on chromosomes XII and XIV) shared with untreated cells and two new sites were observed on chromosomes II and XII (Table R1). Mapping of the Scm3 sites with the tRNA genes and LTRs revealed that these sites from the untreated cells did not overlap with the LTRs (Raveendranathan et al., 2006). However, the same from the treated cells showed overlap with two LTRs on chromosome XVI. No overlap with tRNA genes was observed in the treated cells (Table R1). We next examined Scm3 occupancy at 71 TERs documented in the literature (Fachinetti et al., 2010). Scm3 was found to bind to 6 TERs in both untreated and MMS-treated cells. Notably, MMS treatment resulted in three new peaks, while three peaks were shared with untreated samples (Table R1). Lastly, we compared Scm3 sites with top 25 RNA Pol II sites obtained from the literature (Azvolinsky et al., 2009). In untreated cells, Scm3 was found at only one of these Pol II sites, whereas after MMS treatment, Scm3 sites overlapped with four such sites (Table R1). We further checked the occupancy of Scm3 at a few DSB hotspots (BUD23, ECM3, and CCT6) and DSB coldspot (YCR093W) as mentioned in the literature (Dash et al., 2024; Nandanan et al., 2021). However, we did not find Scm3 binding to these sites. Overall, in-silico analysis of the binding sites indicates that the non-centromeric enrichment of Scm3 occurs at sites that are amenable to DNA damage.” Author response table 1.The table summarising the occupancy of Scm3 in untreated or MMS treated conditions at the indicated regions.RegionChromosomeScm3 occupancy Untreated MMS treated Rrm3 bindingsitesChr IIYESChr XYESChr XIIYESChr XIIYESYESChr XIVYESYESLTRsChr XVIYESChr XVIYEStRNAChr XVYESTERsChr IVYESChr VYESChr VIYESYESChr VIIYESChr XYESChr XYESChr XIVYESYESChr XVYESYESChr XVIYESPol II binding sitesChr IIYESChr XYESChr XIIYESChr XIIYESChr XVYES The table summarising the occupancy of Scm3 in untreated or MMS treated conditions at the indicated regions. It is hard to see what MMS resistance the authors state is observed in Mif2-depleted cells in Figure S3. Perhaps this could be better explained or the claim removed. We agree with the comment and have removed the claim from the manuscript. Protein levels of Scm3 or any of the other factors depleted with AID were never assessed. We have assessed the protein level of Scm3 and a control protein, tubulin using western blotting as per the reviewer’s suggestion (Figure1—figure supplement 2). We did not observe any significant change in the protein levels in SCM3-HA or SCM3-HA-AID cells, suggesting that the AID tagging of Scm3 per se did not make the cells non-functional and the protein was degraded as expected upon addition of auxin. Moreover, the SCM3-AID cells were used previously to examine the effect of Scm3 on kinetochore assembly (Lang et al., 2018). This result has been incorporated as Figure1—figure supplement 2C, and new text has been added in the revised manuscript as: “The depletion of Scm3 was verified by observing a higher percentage of G2/M arrested cells and by Western blot verifying the degradation of Scm3-AID after auxin treatment (Figure 1—figure supplement 2B-C).” in page 5, lines: 142-144. Reviewer #2 (Evidence, reproducibility and clarity (Required)): This manuscript describes a study implicating the Scm3 protein from budding yeast in the DNA damage response (DDR). Scm3 is a chaperone protein, whose main role is considered to be the loading of CENP-A(Cse4) at centromeres to facilitate chromosome segregation. However, the human ortholog of Scm3, HJURP, is known to have a role in DDR and in this study the authors provide evidence that Scm3 is also involved in the DDR in yeast. For the most part, the results presented support the conclusions made. Major comments: A. Figure 1 Could depletion of Scm3 arrest cells in late G2/M and it is this delay that causes increased sensitivity to DNA damaging agents? A control with nocodazole or other means – that also arrests cells at this point – might provide a nice control for this. Perhaps the other kinetochore mutants, used therein, achieve this control – but cell cycle phase would need to be assessed. We thank the reviewer for pointing out to a probable effect of the cell cycle stage on the observed MMS sensitivity. In fact, we were also concerned that the observed DNA damage sensitivity in Scm3 depleted cells might be due to G2/M arrest. To rule out this possibility, we monitored Rad52-GFP foci as a marker for DNA damage in the wild type and Scm3 depleted cells both arrested at G2/M using nocodazole (Figure 2—figure supplement 2). While Scm3 depleted condition exhibited >20% Rad52-GFP positive cells, less than 10% wild type cells showed the same in the absence of any DNA damaging agents (Figure 2—figure supplement 2C, no MMS, 60 mins). Upon challenging these cells with MMS in the presence of nocodazole, Scm3 depleted condition exhibited over 40% Rad52-GFP positive cells, whereas less than 20% wild-type cells harboured Rad52-GFP. This significant increase in Rad52-GFP positive cells when Scm3 is depleted clearly indicates that the observed MMS sensitivity in these cells is due to the absence of Scm3 rather than due to an effect of a cell cycle stage. Furthermore, we have also used Cdc20 depleted G2/M arrested cells as a wild type control to test the activation of the DNA damage checkpoint by Rad53 phosphorylation. These cells showed robust Rad53 activation in response to MMS, in contrast to poor activation in Scm3 depleted cells (Figure 6), suggesting that G2/M arrest is not the reason for the DNA damage sensitivity observed in the latter cells. However, as per the reviewer's suggestion, we examined the MMS sensitivity of the wild type cells arrested at G2/M by nocodazole. As expected, these cells did not show increased sensitivity which further confirms that the DNA damage sensitivity observed in the scm3 mutant is not due to G2/M arrest. This result has been incorporated within Figure 1—figure supplement 3B, replacing the earlier figure. To include this result, we have included new text, and revised the result section in page 5-6, lines 158-179 as follows: “The increased sensitivity of scm3-depleted cells to DNA-damaging agents could be due to the weakening of the kinetochores as Scm3-mediated deposition of Cse4 promotes kinetochore assembly or due to the delay in cell cycle, as Scm3 depleted cells arrest in late G2/M phase (Camahort et al., 2007; Cho and Harrison, 2011). If either of these holds true, perturbation of the kinetochore by degradation of other kinetochore proteins or wild type cells arrested at metaphase must show a similar sensitivity to MMS. In budding yeast, Ndc10 is recruited to the centromeres upstream of Scm3 (Lang et al., 2018), whereas the centromeric localization of Mif2, another essential inner kinetochore protein, depends on Scm3 and Cse4 (Xiao et al., 2017). We constructed NDC10-AID and MIF2-AID strains and used them for our assay to represent the proteins independent or dependent on Scm3 for centromeric localization, respectively. We also included one non-essential kinetochore protein, Ctf19, a protein of the COMA complex, to remove any possible mis-judgement in distinguishing cell-growth-arrest phenotype occurring due to drug-sensitivity vs. auxin-mediated degradation of essential proteins. The COMA complex is directly recruited to the centromeres through interaction with the N terminal tail of Cse4, hence dependent on Scm3 (Chen et al., 2000; Fischböck-Halwachs et al., 2019). Mid-log phase cells were harvested and spotted on the indicated plates, however, we did not observe any increased sensitivity of such cells to MMS (Figure 1—figure supplement 3). Further, wild type cells, when challenged in the presence of nocodazole and MMS, also did not show any increased sensitivity to MMS. Therefore, the increased sensitivity to MMS in scm3 mutant but not in other kinetochore mutant or metaphase arrested cells indicates that Scm3 possesses an additional function in genome stability besides its role in kinetochore assembly.” Further we have also revised the Discussion section to include the observed results in page 15-16, lines 535-539 as follows: “The observed sensitivity is not due to problems in kinetochore formation or cell cycle progression in the absence of Scm3, as other kinetochore mutants or metaphase block in wild type cells did not show similar sensitivity (Figure 1—figure supplement 3), indicating that the drug sensitivity phenotype of Scm3 depleted cells is not due to weakly formed kinetochores or cell cycle delay.” Mutants of the HR pathway in yeast (e.g. rad52∆ with mre11∆ for example) are typically epistatic. The observation that Scm3 depletion is not epistatic with rad52∆ (Figure 1C) suggests the Scm3 acts via another pathway than the classic Rad52 HR pathway. This should be pointed out and discussed. We have now included the discussion “In yeast, although HR is the preferred repair pathway, in the case of perturbed HR, an alternate pathway named non-homologous end joining (NHEJ) can occur. The absence of epistatic interaction between SCM3 and RAD52 (Figure 1C) suggests that Scm3 may function in ways other than the Rad52-mediated classical HR pathway. In this context, it would be interesting to test how Scm3 might interact with the key proteins of the NHEJ pathway, such as Ku70/Ku80 and Lig4 (Gao et al., 2016). It is possible that Scm3 may promote a certain chromatin architecture facilitating the DSB ends to stay together to be accessible for NHEJ-mediated end joining.” in page 16, lines 541-548. Figure 2 should include auxin treatment of RAD52-GFP cells (without the Scm3 degron) to show that the auxin treatment alone does not increase Rad52 foci. We performed the suggested experiment and did not observe any significant increase in Rad52-GFP positive cells when treated the cells with auxin+DMSO as compared to only DMSO. This result has been incorporated as a new supplementary Figure (Figure 2—figure supplement 1A-B) and new text has been added in the revised manuscript as “To rule out the possibility that auxin treatment alone can cause increased Rad52-GFP foci formation, we challenged the wild type (RAD52-GFP) cells with auxin or DMSO and counted the number of cells with Rad52-GFP foci. We did not observe any increase in Rad52-GFP positive cells when treated with auxin+DMSO as compared to only DMSO (Figure 2—figure supplement 1A-B).” in page 7, lines: 231-235. Line 246-247 For the data presented, it seems to me possible that Scm3 depleted cells may indicate a defective DDR pathway (as stated) or may indicate defects in DNA replication or an increase in some other form of DNA damage? We agree with the reviewer’s comment that the depletion of Scm3 can cause replication error or other form of DNA damage in addition to the defect in DDR pathway. To include this, we have modified the sentence as “Taken together, Scm3 depleted cells exhibit more Rad52 foci, indicating a compromised DDR pathway in these cells. However, defects in DNA replication or creation of other DNA lesions producing more foci also cannot be ruled out.” in page 8, lines 254-256. In Figure 1 and throughout, please describe in the figure legends how error bars and p values are derived, and the number of experiments involved. We have now verified all the figure legends and described how error bars and p values are derived and have mentioned the number of experiments involved. Line 35 replace 'cell survival' with 'cell division' – non-dividing cells can survive fine without chromosome segregation. See also line 62. We have now changed ‘cell survival’ with ‘cell division’ in lines 35 and 62. Line 52 and throughout, I suggest replacing CenH3 with CENP-A or Cse4. The term CenH3 is confusing since regional centromeres contain both CENP-A nucleosomes and H3 nucleosomes – the latter of which can also be called CenH3 nucleosomes. We have replaced CenH3 with CENP-A or Cse4 at the appropriate locations. Lines 69-79 specific references are needed for the sentences starting "HJURP was so named…", "In addition,…", "As a corollary,…" and "Finally,…" The final sentence of this paragraph, starting "Perhaps due to…" is unclear. We have included the reference as mentioned by the reviewer. Also, we have changed the last line as “Notably, HJURP has been visualized to be diffusely present throughout the nucleus (Dunleavy et al., 2009; Kato et al., 2007), possibly due to its global chromatin binding and involvement in DDR.” in page 3, lines 74-76. Line 96 "gross chromatin" is unclear; also line 476. We have changed gross chromatin to “bulk of the chromatin.” and incorporated it into the main text. Line 103 "dimerize" We have replaced ‘dimerizes’ with ‘dimerize’. Line 109 "most" and "highly" don't work together – perhaps better to say "the functions appear conserved from humans to yeast". have changed the wording as the reviewer suggested. Line 175 "grown" to "phase", see also line 223. We have changed the wording as the reviewer suggested. Line 293 delete "besides" We have deleted the word ‘besides’. Figure 5 – panels C and D, please make x axis labels clearer – they are directly underneath the 2kb ChIP. They should include a horizontal bar to indicate that all 5 ChIP experiments are included in each time point. We have now included a horizontal bar in both Figure 5 and the corresponding supplementary Figure 5—figure supplement 1, to better represent the ChIP experiments. We thank the reviewer for pointing this out. Reviewer #3 Major comments: A. The quantification in Figure 3B is not clear. Is it done on a per/nuclei basis? What pools of Scm3 and Ndc10 are being normalized? We have now included a separate paragraph in Materials and methods regarding the gel run, processing and quantification of the western blots in the revised manuscript for better understanding of the readers: “To detect Scm3-6HA, Rad53, and γ-H2A, the total proteins isolated from the appropriate cells were run on 12%, 8%, and 15% SDS gels, respectively. The proteins were transferred to the membranes, which were cut to detect the above proteins and the control protein tubulin separately. For the quantification of the bands on the western blots, a region of interest (ROI) was made around the band of interest, and the intensity of the band was calculated using ImageJ. A same ROI from a no-band area of the blot was used to calculate the background intensity. The background intensity was subtracted from the band intensity. The same process was done for the tubulin bands. The intensity of the target bands (Scm3-6HA, Rad53, and γ-H2A) was divided by control tubulin band intensity to get the normalized values for the target bands, which were plotted using GraphPad Prism 9.0 (Version 9.4.1) software.” This has been added in page 25, lines: 890-899. We have now replaced Figure 6D with Figure 6B with a better blot representing the reduced Rad53 phosphorylation in scm3 as compared to cdc20. For Figure 7D, we have reprocessed the image and also deposited uncropped and unprocessed source blots depicting different blots that were run to detect Scm3 and tubulin. Line 103: not clear what "both the proteins dimerize" means…probably should be "both proteins dimerize" We have changed the wording to “both proteins dimerize”. The argument that Ndc10 does not have a growth defect on MMS is a weak conclusion, given that almost no control cells grow on auxin in the absence of MMS. We have now repeated the spotting assay with a lesser concentration of auxin and replaced Figure S3 with a new Figure 1—figure supplement 3 to better represent and conclude that the loss of Ndc10 does not cause MMS sensitivity. 4. Description of analyses that authors prefer not to carry out Reviewer #3 Minor comments: A. The model is elegant but there are chromatin pools (beyond the kinetochore pool) of Scm3 that do not contain Rad52 and/or γ-H2X and vice versa. It would be helpful if the authors could speculate on how to reconcile these different pools. It might be premature to suggest such a detailed model at this point since the function of Scm3 in the checkpoint is still very unclear so I would encourage the authors to make a less detailed model. By showing the green hallow, we have depicted the nuclear pool of Scm3, and we have not shown that the pool contains DDR proteins viz., Rad52 or g-H2A. Rather, we have shown the recruitment of these proteins at the DNA damage sites. Since the focus of this manuscript is on the non-centromeric functions of Scm3, we have not shown the kinetochore pool of Scm3. Although the model is a detailed one, the contribution from this work has been mentioned legitimately at every stage so that the readers can judge the merit of this work. We believe that a detailed model would provide a better perspective to the readers to correlate the revealed as well as yet-to-reveal functions of Scm3 in a spatiotemporal manner with the other players of the DDR pathway. Therefore, we prefer to keep the model in a detailed form. [Editors’ note: what follows is the authors’ response to the second round of review.] Based on your manuscript, the reviews and your responses, we invite you to submit a revised version incorporating the revisions as outlined in your response to the reviews. When preparing your revisions, please also address the following points: (1) For the reported Scm3 phosphorylation, please include a control where samples have been treated with phosphatase to demonstrate that observed shifts are due to phosphorylation. We thank the editor for the suggestion. We have now performed a phosphatase assay demonstrating the shifts are indeed due to Scm3 phosphorylation. Figure 7—figure supplement 1F shows the disappearance of the Scm3 phosphorylated species (Scm3*) after treatment with alkaline phosphatase. We have included this in the manuscript in Figure 7—figure supplement 1 and incorporated in the text as follows on page 15 lines 521-525: “We further verified this by performing a phosphatase experiment. SCM3-6HA cells treated or untreated with MMS were immunoprecipitated and subjected to alkaline phosphatase treatment for 3 hrs at 37°C. The disappearance of the Scm3* band upon phosphatase treatment confirms that the shift was indeed due to phosphorylation (Figure 7—figure supplement 1F).” We have now also included this in the Materials and methods section as follows on pages 25-26 lines 897-909 as follows: “For phosphatase treatment, cell lysates were prepared in lysis buffer (25 mM HEPES, pH7.5, 2 mM MgCl2, 0.1 mM EDTA, 0.5 mM EGTA, 0.1 % NP-40, 15 % glycerol, 80 mM NaF) supplemented with 1X PMSF, 1X PIC, 1X Phos-Stop. The cells were lysed using 0.5 mm glass beads using a mini-bead beater (BIOSPEC, India) for 7 cycles (1 min ON, 2 mins OFF on ice). After clarification of the lysate by centrifugation, 5 µg of anti-HA antibodies (ab9110, Abcam) was added and incubated at 4°C overnight with gentle rotation followed by incubation with Protein G conjugated Dynabeads (10003D, Invitrogen) for 2 hrs at 4°C with rotation. The beads were washed thrice with lysis buffer followed by three times washing in phosphatase wash buffer (50 mM HEPES, pH 7.5; 0.2 mM MnCl2, 100 mM NaCl, 5% glycerol, 2 mM β-mercaptoethanol). The eluate was resuspended in phosphatase buffer and incubated with or without FastAP (EF0651, Thermo) for 3 hrs at 37°C. After incubation, the proteins were eluted in 1X SDS-PAGE buffer, samples were run on 12% SDS gel, and immunoblotting was performed using anti-HA antibodies.” (2) For Figure 5C, you conclude that there is no significant enrichment at the TUB2 locus (page 11), but this has not been statistically tested, and there does seem to be considerable enrichment at the 2-hour time point. In Figure 5C, the statistical analyses were given in a pairwise fashion between each locus and the TUB2 locus. At the TUB2 locus, no significant enrichment of Scm3-6HA was found at different time points of HO induction (Figure 5—figure supplement 1). However, we have now performed a separate statistical analysis for the enrichment of Scm3 at both CEN3 and TUB2 loci (Figure R2) and incorporated the results in the text on page 12 lines 411-416 as follows: “To confirm that the enrichment of Scm3 at 2 hrs at the HO-induced DSB sites is a site-specific response rather than a global chromatin enrichment, we verified the enrichment of Scm3-6HA at the CEN3 and TUB2 loci at different time points of HO induction. We could not observe any significant enrichment of Scm3 at those loci over different time points, suggesting Scm3 specifically enriches at the DSB sites upon DNA damage (Figure 5—figure supplement 1D, E).” (3) For the ChIP experiment (Figure 3), are controls for the metaphase arrest available? Was the arrest similarly tight for the untreated and the MMS-treated sample? The samples were first analysed for metaphase arrest by DAPI staining before proceeding with ChIP. Figure 3—figure supplement 1A shows that both MMS treated and untreated cells were similarly arrested at the metaphase stage. We are thankful to the editor for this comment. We have included this new supplementary figure: Figure 3—figure supplement 1A and incorporated in the text as follows on page 8 lines 282-283. “Both the MMS treated and untreated samples were similarly arrested as judged by DAPI staining prior to ChIP-seq assay (Figure 3—figure supplement 1A).” (4) I cannot follow the argument about the enrichment of Scm3 after MMS treatment by ChIP (Figure 3). Almost all the peaks pointed out by black arrows are also observed in untreated cells. Please explain how this has been quantitatively assessed and provide additional metrics on all peaks observed without or with MMS treatment (more comprehensive than Table S1). How much of the variation observed is inter-experiment variability? We thank the editor for the comment and agree that the ChIP-seq data presentation in its current form might be confusing. We have now provided a revised version of Figure 3 with a better representation of the Scm3-binding peaks by using distinct and different colored bars that explain the ChIP-seq data in a much better way. We have quantitatively analysed the peaks obtained in the untreated and treated samples, and only those sites where the enrichment upon immunoprecipitation (in the treated or untreated sample) exceeds that of the input by more than one-fold are considered as the true peaks. Upon quantification from MACS2 results, we observed that in the untreated samples, 17 peaks were enriched (~1.4-1.8 fold) compared to the input, while 75 peaks were enriched (~1.3-1.9 fold) in the MMS treated samples at the non-centromeric sites (Figure 3—figure supplement 1B, Figure 3D). Out of these peaks, two were commonly found in both samples. One peak was found in the FLO1 gene of Chr II, while the other peak was found in the CT repeat region of the indole pyruvate decarboxylase1 gene of Chr XII. Interestingly, as commented by the reviewer, we observed ~1.4 fold enrichment of Scm3 binding at the rDNA, that harbors repetitive regions, in the treated cells (1.54 fold enrichment relative to input) compared to untreated cells (1.06 fold enrichment relative to input) (Figure 3E) suggesting its general preference towards such regions. This analysis clearly demonstrates an increase in the binding of Scm3 to the non-centromeric sites upon MMS treatment. To further understand the nature of the non-centromeric sites harboring the enriched peaks (17 untreated, 75 treated) they were scanned for the presence of any motifs, and we observed three and one significant motifs (Figure 3—figure supplement 1F) in the treated and in the untreated samples, respectively. The three motifs in the MMS treated samples were specifically observed in the viral LTR region of the gag-pol fusion gene, based on the annotation from the NCBI reference genome (NCBI accession: GCF_000146045.2). These viral LTRs are found in multiple chromosomes spanning 29 peaks (~39% of total peaks) in the treated samples. Interestingly, these regions are considered fragile sites marked by the binding of Rrm3 helicase (Song et al., 2014). Notably, these viral LTRs are also known to trigger DNA-damage response pathways (Sinclair et al., 2006). This suggests that upon DNA damage induction, Scm3 is recruited to genomic locations that are more prone to damage, perhaps by interaction with DNA damage repair proteins. This can be argued based on the increased co-localization of Scm3 with DNA damage repair proteins Rad52, and y-H2A (Figure 4 of the manuscript) and the recruitment of Scm3 to the HO-induced DSB site (Figure 5 of the manuscript), where Scm3 binds DNA up to -3 kb from the DNA cut site, and its enrichment correlates with the binding of Rad51, a DNA damage repair protein. Additionally, we also scanned the peaks for different features and observed that MMS treated peaks comprise fragile sites (Song et al., 2014) and hotspots (Gerton et al., 2004), which are prone to DNA damage. The untreated samples had a comparatively smaller number of such damage-prone sites (Figure 3—figure supplement 1C). Moreover, the MMS treated samples had a higher number of peaks with short tandem repeats (length 5-7 nucleotides), interspersed repeats and low complexity regions (less diversity of nucleotides). These repeat regions are also shown to be a source of DNA damage, as they form alternative non-B DNA structures, which are more prone to damage (Brown et al., 2021; Wierdl et al., 1997). Further gene set enrichment analysis of the 17 non centromeric peaks in untreated cells revealed that Scm3 binds to regions that are involved in normal metabolic pathways such as glycolysis/gluconeogenesis, regulation of amino acids, and telomere maintenance (Figure 3—figure supplement 1E) while in the treated samples the 75 non-centromeric peaks had GO terms/pathways that are mostly related to nucleotide synthesis and detoxification/flocculation, which are usually triggered in stress conditions (Figure 3—figure supplement 1D). We speculate that Scm3 might bind to these genes to ameliorate the DNA damage stress caused by MMS treatment. Hence, we could attribute the increased binding of the Scm3 to the non-centromeric regions to DNA damage/repair. Based on our analysis, we have edited the manuscript as follows on pages 9-10, lines 287-329: “The Scm3 ChIP-seq signal was normalised with the input signal, and upon quantification from MACS2, we observed the enrichment (peaks) of Scm3 at all 16 centromeres in both untreated and MMS treated samples (Figure 3D, blue bars). Scm3 was also enriched at the 9.1 kb rDNA region on Chr XII in both untreated and treated samples (Figure 3E, at rDNA), consistent with our chromatin spread data (Figure 3A). Upon further analysis, the enrichment of Scm3 at rDNA, which harbours repetitive regions, was found to be ~1.4-fold in the treated cells (1.54-fold enrichment relative to input) compared to untreated cells (1.06-fold enrichment relative to input) (Figure 3E), suggesting its general preference towards such regions. Besides the centromeric peaks, 17 non-centromeric peaks (~1.4–1.8-fold enrichment over input) were detected in untreated samples, compared to 75 peaks (~1.3–1.9-fold enrichment over input) in MMS-treated cells, in which only two peaks were shared (Figure 3—figure supplement 1B). This analysis clearly demonstrates an increase in the binding of Scm3 to the non-centromeric sites upon MMS treatment. The feature analysis of these sites revealed that MMS treated samples were enriched in peaks which comprise fragile sites (Song et al., 2014) and recombination hotspots (Gerton et al., 2004), which are prone to DNA damage. The untreated samples had a comparatively smaller number of such damage-prone sites (Figure 3—figure supplement 1C, fragile sites and hotspots). Moreover, the MMS treated samples had a higher number of peaks with short tandem repeats (length 5-7 nucleotides), interspersed repeats and low complexity regions (less diversity of nucleotides) than in the untreated samples. These repeat regions are also shown to be a source of DNA damage, as they form alternative non-B DNA structures, which are more prone to damage (Brown et al., 2021; Wierdl et al., 1996). Furthermore, analysis of the gene ontology (GO) associated with the 17 non-centromeric peaks revealed GO terms that are involved in normal metabolic pathways such as glycolysis/gluconeogenesis, regulation of amino acids, and telomere maintenance (Figure 3—figure supplement 1E) while in the treated samples the 75 non-centromeric peaks had GO terms that are mostly related to nucleotide synthesis and detoxification/flocculation, which are usually triggered in stress conditions (Figure 3—figure supplement 1D).We speculate that Scm3 might bind to these genes to ameliorate the DNA damage stress caused by MMS treatment. Hence, we could attribute the increased binding of the Scm3 to the non-centromeric regions to DNA damage. To further understand the nature of the non-centromeric sites harboring the enriched peaks (17 untreated, 75 treated), they were scanned for the presence of any motifs, and we observed three and one significant motifs in the treated and in the untreated samples, respectively (Figure 3—figure supplement 1F). The three motifs in the MMS treated samples were specifically observed in the viral LTR region of the gag-pol fusion gene, based on the annotation from the NCBI reference genome (NCBI accession: GCF_000146045.2). These viral LTRs are found in multiple chromosomes spanning 29 peaks (~39% of total peaks) in the treated samples. Interestingly, these regions are considered fragile sites marked by the binding of Rrm3 helicase (Song et al., 2014). Notably, these viral LTRs are also known to trigger DNA-damage response pathways (Sinclair et al., 2006). This suggests that upon DNA damage induction, Scm3 is recruited to genomic locations that are more prone to damage, perhaps by interaction with DNA damage repair proteins.” (5) In Figure 4, given the limited resolution of light microscopy, is it possible that any chromatin-associated protein would show an increased co-localization with Rad52 or γ-H2A (since the area of occupancy expands)? Please include a negative control, e.g. a transcription factor. We are thankful to the editor for pointing to include the negative control. In the revised version, we have included Hsf1, a transcription factor, as a negative control in the co-localization assay. We examined co-localisation between y-H2A and Hsf1-13Myc and unlike Scm3-6HA, found no increased co-localisation in response to MMS or heat shock between the two proteins (Figure 4—figure supplement 2). The result has been incorporated in the text as follows on pages 10-11 lines 346-356: “In order to negate the possibility that the increased co-localisation of Scm3-6HA with Rad52 or γ-H2A following MMS treatment is merely due to the increased accumulation of the DDR proteins in response to MMS within the small yeast nucleus, we tested the colocalization of an unrelated transcription factor, Hsf1, with γ-H2A. Since Hsf1 is known to increase its chromatin association in response to heat shock (Chowdhary et al., 2019; Rubio et al., 2024), we verified this by incubating the cells at 37°C for 15 mins. As expected, Hsf1 showed an increased chromatin association (a greater number of Hsf1-13Myc foci) at high temperatures compared to normal temperatures (Figure 4—figure supplement 2A-C). As expected, the increased chromatin occupancy of Hsf1 or γ-H2A due to high temperature or MMS treatment, respectively, did not result in any significant increase in the co-localization frequency between the two proteins (Figure 4—figure supplement 2D-F).” We further verified if the assay was sensitive enough and does not show an increased co-localisation due to the limited resolution of light microscopy. For clarity of the experiment, we recalculated the PCC values by rotating the red image 180° as performed in our earlier studies (Ma et al., 2023). As per the analysis, we did not observe any significant increase in the PCC values after the MMS treatment, suggesting that the observed values (Figure 4D) are not an artefact due to experimental errors (Figure 4—figure supplement 1). We have included these results in the manuscript on page 11 lines 359-364 as follows: “We verified the accuracy of the assay by rotating the red and green fluorescence images through 180° relative to each other and recalculating the PCC value as described earlier (Ma et al., 2023). After rotation, we failed to observe any significant correlation between Scm3-13Myc and γ-H2A (Figure 4—figure supplement 1G-I), suggesting the observed high PCC values (Figure 4D-F) are not an artefact of the assay.” (6) When independent experiments were conducted (e.g. for Figure 2C/D, Figure 3B, Figure 4B/D, Figure 6E, S2B, etc.), please show the mean of each independent experiment, either in the main figure or in a separate supplemental figure. Statistical tests should additionally be conducted based on n = 3 experiments, not n > 300 cells. We have now edited all the figures to represent the mean of each experimental replicate. (7) Please revise the title and incorporate "budding yeast" or "Scm3" into the title. We have revised the title to “Evidence of centromeric histone 3 chaperone involved in DNA damage repair pathway in budding yeast.” (8) Please try to shorten the discussion and avoid re-iterating results already covered in the Results section. We have now shortened the discussion as per the suggestion. (9) Please be careful not to overstate the results. As one example: page 14 "Scm3… associates with the DDR proteins at the DNA damage sites." A direct protein-protein interaction has not been demonstrated. So please rephrase. It has been reworded to “Scm3 possibly associates with the DDR proteins at the DNA damage sites”. (10) In the abstract, line 24, "interacts with…" should be "genetically interacts with…". We have made the necessary changes. (11) Line 203: Please rephrase "also referred to as the NLS". NLS is not a synonym for a bromodomain. Therefore, "..which also harbor an NLS" or "… which also harbor a candidate NLS" would be more appropriate. The statement has been modified to “which also harbors a candidate NLS.” (12) Please have the manuscript proofread for English grammar and spelling, in particular the introduction. We have now corrected all the grammatical errors. [Editors’ note: what follows is the authors’ response to the third round of review.] Two major remaining concerns were not sufficiently addressed by the revision: (1) The claim that the DDR checkpoint is impaired in Scm3-depleted cells is not substantiated. The new immunoblot in Figure 6A (formerly 6D) still shows no obvious reduction of Rad53 phosphorylation in Scm3-depleted cells. The quantification of perturbed Rad53 phosphorylation is shown in Figure 6—figure supplement 1B, C, where in Scm3-depleted cells, the phosphorylation of Rad53 (activation of DDR checkpoint) is significantly reduced. This has been further verified in Figure 6A (new immunoblot). The quantification of the blot was not performed as both at early (30 mins and 60 mins) and late time points (240 mins), we can clearly see reduced levels of Rad53 phosphorylation in Scm3-depleted cells as compared to Cdc20-depleted cells. Similarly, the new immunoblot for Pds1 in Figure 6E does not give any strong indication that Pds1 degrades earlier in Scm3-depleted cells. (Compare, for example: https://pmc.ncbi.nlm.nih.gov/articles/PMC312708/figure/F5/). We have now quantified the levels of Pds1 from the graph, and the image below (Figure S1) shows that Pds1 levels are low as it is degraded faster in the absence of Scm3. This is also supported by the presence of anaphase cells at later time points, suggesting that due to the degradation of Pds1, cells bypass the metaphase arrest due to MMS and proceed to anaphase with ploidy problems. (2) The ChIP-seq experiment remains largely inconclusive regarding whether there is increased binding of Scm3 to chromatin after MMS treatment and whether there is enrichment at fragile sites. The ChIP profiles from untreated and MMS-treated cells look highly similar, and it remains unclear whether differences in peak height between control and MMS are inter-experiment variability or MMS-induced changes. While a few Scm3 peaks overlap with fragile sites based on the new data you report, this is the case both in untreated and in MMS-treated cells. There is no clear increase after MMS treatment and in fact, some sites lose Scm3 enrichment after MMS treatment. Based on the ChIP-seq data, we detected 33 Scm3 peaks in untreated cells and approximately three times more (90 peaks) in MMS-treated cells. This indicates a potential increase in Scm3 chromatin association following MMS treatment. Previous studies have shown that Scm3 is not restricted to centromeres (Xiao et al., 2011; Wisniewski et al., 2014), and cells lacking Scm3 exhibit partial S-phase arrest; this could be the reason why Scm3 binds to a few fragile sites even without DNA damage. Notably, a greater number of Scm3 peaks are observed at fragile sites after MMS exposure; since untreated cells themselves show Scm3 binding to a few fragile sites, the difference is not as apparent. However, this does not change the fact that Scm3 interacts with fragile sites, and rDNA apart from centromeric regions. The presence of Scm3 at fragile sites, even in the absence of drug treatment, and its increased binding after MMS exposure, highlights the potential importance of Scm3 in maintaining genome stability in these vulnerable regions.